{"question_id": 2003, "title": "How many COVID-19 vaccines will be authorized for emergency use or approved by the US FDA as of 31 December 2021?", "possible_answers": ["2 or fewer", "3", "4", "5", "6 or more"], "crowd_forecast": [0.0, 1.0, 0.0, 0.0, 0.0], "correct_answer": "3", "correct_forecast": 1.0, "preds": [[38, "2022-01-01T02:10:25Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [103878, "2021-12-30T23:43:44Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [52131, "2021-12-29T20:19:31Z", [0.0, 0.95, 0.05, 0.0, 0.0], ""], [103822, "2021-12-29T11:57:31Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [40636, "2021-12-29T10:52:08Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [96828, "2021-12-29T01:24:01Z", [0.0, 0.99, 0.01, 0.0, 0.0], "https://www.foxbusiness.com/healthcare/novavax-at-tipping-point-with-covid-vaccine-ceo\nhttps://www.youtube.com/watch?v=6rWvKGToTis"], [87827, "2021-12-28T20:14:12Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [530, "2021-12-28T18:13:53Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [96828, "2021-12-28T02:01:51Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [103055, "2021-12-27T16:50:24Z", [0.08, 0.92, 0.0, 0.0, 0.0], ""], [97375, "2021-12-26T20:19:25Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [97302, "2021-12-26T03:09:30Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [97497, "2021-12-26T00:22:19Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [96828, "2021-12-25T23:26:43Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [98850, "2021-12-25T21:24:03Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [43003, "2021-12-25T21:07:15Z", [0.0, 1.0, 0.0, 0.0, 0.0], "At this point, there is a lull in all government agencies from Dec 22 to Jan 3. While it is possible that another drug will be approved, the probability is under 0.5% so I will have to round down to 0%."], [103822, "2021-12-25T17:07:18Z", [0.0, 0.95, 0.05, 0.0, 0.0], ""], [24440, "2021-12-25T14:14:18Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [13086, "2021-12-22T12:39:30Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [34959, "2021-12-22T05:45:28Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [103055, "2021-12-22T05:16:32Z", [0.08, 0.92, 0.0, 0.0, 0.0], ""], [530, "2021-12-21T23:42:21Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [59836, "2021-12-21T19:45:41Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [53382, "2021-12-21T03:48:44Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [86607, "2021-12-20T22:08:09Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [80667, "2021-12-20T21:26:42Z", [0.0, 1.0, 0.0, 0.0, 0.0], "3 seems to be most likely!"], [29680, "2021-12-18T02:39:05Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [87827, "2021-12-17T16:38:33Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [94872, "2021-12-17T01:25:11Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [20156, "2021-12-16T11:01:31Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [96828, "2021-12-16T09:57:32Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [88452, "2021-12-16T08:39:29Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [96847, "2021-12-14T23:20:12Z", [0.0, 0.86, 0.14, 0.0, 0.0], ""], [530, "2021-12-14T21:35:25Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [88098, "2021-12-14T07:18:18Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [103702, "2021-12-13T16:20:53Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [75649, "2021-12-13T15:16:19Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [75649, "2021-12-13T15:15:49Z", [1.0, 0.0, 0.0, 0.0, 0.0], ""], [29054, "2021-12-12T14:07:50Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [90560, "2021-12-11T02:36:17Z", [0.0, 0.0, 1.0, 0.0, 0.0], ""], [103650, "2021-12-09T19:15:07Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [87342, "2021-12-08T22:01:57Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [99993, "2021-12-08T18:55:56Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [87827, "2021-12-08T17:13:36Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [67312, "2021-12-08T11:30:46Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [530, "2021-12-07T20:41:07Z", [0.0, 0.97, 0.03, 0.0, 0.0], ""], [94872, "2021-12-07T05:29:55Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [98345, "2021-12-07T03:19:28Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [88098, "2021-12-06T00:52:12Z", [0.0, 0.96, 0.04, 0.0, 0.0], ""], [67312, "2021-12-05T22:56:11Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [99375, "2021-12-05T15:58:13Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [99780, "2021-12-05T11:22:20Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [101499, "2021-12-04T22:28:56Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [530, "2021-12-03T15:51:08Z", [0.0, 0.97, 0.03, 0.0, 0.0], ""], [20156, "2021-12-03T09:44:21Z", [0.0, 0.98, 0.02, 0.0, 0.0], ""], [45594, "2021-12-02T20:35:32Z", [0.0, 0.8, 0.15, 0.05, 0.0], ""], [88452, "2021-12-02T09:30:00Z", [0.0, 0.97, 0.03, 0.0, 0.0], ""], [103429, "2021-12-02T03:35:04Z", [0.0, 1.0, 0.0, 0.0, 0.0], "Novavax only seeking submission for approval by the end of the year, so not enough time for approval. AstraZeneca and other vaccines from outside US have been \u201cdead in the water\u201d in the approval process due to medical or regulatory issues. A 4th vaccine approval will not occur until 2022. https://www.forbes.com/sites/joshuacohen/2021/11/03/if-approved-the-novavax-covid-19-vaccine-could-help-reduce-vaccine-hesitancy-in-the-us/"], [55987, "2021-12-01T16:11:45Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [67312, "2021-11-30T22:37:34Z", [0.0, 0.98, 0.02, 0.0, 0.0], ""], [13086, "2021-11-29T18:54:33Z", [0.0, 0.99, 0.01, 0.0, 0.0], "Narrowing time scales reducing towards Christmas"], [96828, "2021-11-27T23:45:08Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [691, "2021-11-27T16:45:39Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [101989, "2021-11-27T10:45:53Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [101187, "2021-11-27T09:20:23Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [94872, "2021-11-26T22:20:12Z", [0.0, 0.98, 0.02, 0.0, 0.0], ""], [88452, "2021-11-26T12:34:27Z", [0.0, 0.34, 0.32, 0.34, 0.0], ""], [78587, "2021-11-25T21:49:33Z", [0.0, 0.0, 0.0, 0.8, 0.2], ""], [691, "2021-11-25T19:48:30Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [22689, "2021-11-25T03:06:05Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [98850, "2021-11-24T23:17:55Z", [0.0, 0.98, 0.02, 0.0, 0.0], "Why would they approve a new one now?"], [14432, "2021-11-24T17:52:47Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [88452, "2021-11-24T11:53:58Z", [0.0, 0.75, 0.23, 0.02, 0.0], ""], [99993, "2021-11-23T23:44:17Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [102644, "2021-11-23T17:51:05Z", [0.0, 0.86, 0.14, 0.0, 0.0], ""], [102645, "2021-11-23T17:35:10Z", [0.0, 0.8, 0.2, 0.0, 0.0], ""], [73687, "2021-11-23T00:02:51Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [34959, "2021-11-22T15:44:38Z", [0.0, 0.97, 0.03, 0.0, 0.0], ""], [87827, "2021-11-22T15:43:07Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [13086, "2021-11-22T15:12:47Z", [0.0, 0.97, 0.02, 0.01, 0.0], "Pfizer will continue to frustrate the process of any further authorizations in the short term"], [103233, "2021-11-22T03:13:52Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [67312, "2021-11-22T02:28:18Z", [0.0, 0.94, 0.06, 0.0, 0.0], ""], [88098, "2021-11-22T01:07:10Z", [0.0, 0.92, 0.08, 0.0, 0.0], ""], [94872, "2021-11-20T05:22:58Z", [0.0, 0.96, 0.04, 0.0, 0.0], ""], [102645, "2021-11-19T17:42:09Z", [0.0, 0.8, 0.2, 0.0, 0.0], ""], [95503, "2021-11-19T17:23:59Z", [0.0, 0.94, 0.06, 0.0, 0.0], ""], [103290, "2021-11-18T23:53:24Z", [0.0, 0.8, 0.2, 0.0, 0.0], ""], [98345, "2021-11-18T15:44:39Z", [0.0, 0.97, 0.03, 0.0, 0.0], ""], [20156, "2021-11-18T10:54:49Z", [0.0, 0.91, 0.09, 0.0, 0.0], ""], [84880, "2021-11-18T03:29:00Z", [0.0, 0.96, 0.04, 0.0, 0.0], ""], [87342, "2021-11-17T23:53:13Z", [0.0, 0.95, 0.05, 0.0, 0.0], ""], [530, "2021-11-17T16:26:52Z", [0.0, 0.91, 0.06, 0.03, 0.0], ""], [88452, "2021-11-16T15:16:09Z", [0.0, 0.55, 0.39, 0.06, 0.0], ""], [99780, "2021-11-15T21:18:01Z", [0.0, 0.98, 0.02, 0.0, 0.0], ""], [95503, "2021-11-15T17:35:44Z", [0.0, 0.86, 0.14, 0.0, 0.0], ""], [13086, "2021-11-12T21:26:32Z", [0.0, 0.96, 0.03, 0.01, 0.0], ""], [530, "2021-11-12T19:21:47Z", [0.0, 0.91, 0.06, 0.03, 0.0], ""], [99943, "2021-11-11T16:59:38Z", [0.0, 1.0, 0.0, 0.0, 0.0], "Aside from the speculation that the Novavax vaccine isn't likely to be authorized any time soon, it's also getting really late to submit an application and have it authorized by the end of the year."], [55987, "2021-11-09T16:13:56Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [102649, "2021-11-09T14:03:54Z", [0.13, 0.25, 0.22, 0.2, 0.2], ""], [88098, "2021-11-09T13:29:26Z", [0.0, 0.9, 0.1, 0.0, 0.0], ""], [87155, "2021-11-08T19:39:44Z", [0.0, 0.95, 0.05, 0.0, 0.0], ""], [88098, "2021-11-08T00:45:47Z", [0.0, 0.88, 0.12, 0.0, 0.0], ""], [96828, "2021-11-07T23:58:55Z", [0.0, 0.97, 0.03, 0.0, 0.0], ""], [67312, "2021-11-07T23:06:27Z", [0.0, 0.93, 0.07, 0.0, 0.0], ""], [691, "2021-11-07T15:02:03Z", [0.0, 0.94, 0.06, 0.0, 0.0], ""], [94872, "2021-11-07T01:32:19Z", [0.0, 0.92, 0.08, 0.0, 0.0], ""], [99780, "2021-11-05T20:50:40Z", [0.0, 0.96, 0.04, 0.0, 0.0], ""], [691, "2021-11-05T15:51:51Z", [0.0, 0.92, 0.08, 0.0, 0.0], ""], [67312, "2021-11-04T23:04:55Z", [0.0, 0.92, 0.08, 0.0, 0.0], ""], [87827, "2021-11-04T18:41:18Z", [0.0, 0.85, 0.15, 0.0, 0.0], ""], [99993, "2021-11-04T16:49:48Z", [0.0, 0.95, 0.05, 0.0, 0.0], ""], [34959, "2021-11-04T15:39:03Z", [0.0, 0.91, 0.09, 0.0, 0.0], ""], [55987, "2021-11-04T15:25:41Z", [0.0, 0.95, 0.05, 0.0, 0.0], ""], [14266, "2021-11-04T03:40:45Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [101989, "2021-11-02T17:35:09Z", [0.0, 0.9, 0.1, 0.0, 0.0], ""], [530, "2021-11-02T17:26:28Z", [0.0, 0.91, 0.06, 0.03, 0.0], ""], [95503, "2021-11-02T11:43:17Z", [0.0, 0.73, 0.25, 0.02, 0.0], ""], [55987, "2021-11-01T15:44:35Z", [0.0, 0.94, 0.06, 0.0, 0.0], ""], [98850, "2021-10-31T23:03:31Z", [0.0, 0.85, 0.15, 0.0, 0.0], "Does not seem like the FDA is in any rush to approve other vaccines. We don't even need the doses we have because Americans aren't getting the shots."], [88452, "2021-10-31T18:58:47Z", [0.0, 0.41, 0.5, 0.09, 0.0], ""], [691, "2021-10-31T14:41:37Z", [0.0, 0.89, 0.11, 0.0, 0.0], ""], [34959, "2021-10-31T14:11:11Z", [0.0, 0.87, 0.13, 0.0, 0.0], ""], [67312, "2021-10-31T11:34:45Z", [0.0, 0.81, 0.19, 0.0, 0.0], ""], [20156, "2021-10-29T07:37:19Z", [0.0, 0.82, 0.18, 0.0, 0.0], ""], [99993, "2021-10-28T20:25:38Z", [0.0, 0.89, 0.1, 0.01, 0.0], ""], [101187, "2021-10-27T18:22:16Z", [0.0, 0.95, 0.05, 0.0, 0.0], ""], [95503, "2021-10-27T16:47:24Z", [0.0, 0.65, 0.33, 0.02, 0.0], ""], [102048, "2021-10-27T14:51:36Z", [0.0, 0.94, 0.05, 0.01, 0.0], ""], [55987, "2021-10-27T14:07:27Z", [0.0, 0.91, 0.09, 0.0, 0.0], ""], [530, "2021-10-27T13:39:04Z", [0.0, 0.8, 0.17, 0.03, 0.0], ""], [88098, "2021-10-27T12:00:27Z", [0.0, 0.85, 0.15, 0.0, 0.0], ""], [55987, "2021-10-26T15:38:21Z", [0.0, 0.84, 0.16, 0.0, 0.0], ""], [87827, "2021-10-26T15:11:03Z", [0.01, 0.78, 0.2, 0.01, 0.0], "Continuing to drop as time passes with no news. Astrazeneca (3%, down 7 on no news)\nNovavax (15%, down 25 on the Politico article suggesting they can't satisfy manufacturing requirements currently)\nSanofi/GSK (5%, down 15 on passage of time and it sounds like phase 3 is ongoing, may not complete in time)\nOther (1%, same as last) Calculator: https://docs.google.com/spreadsheets/d/1BEukXZ_IOMEESxaMPD216qugBo7kppVRbXuqp-pPmNg/edit?usp=sharing"], [94872, "2021-10-26T03:58:16Z", [0.0, 0.9, 0.1, 0.0, 0.0], ""], [98345, "2021-10-26T03:06:35Z", [0.0, 0.95, 0.05, 0.0, 0.0], ""], [96828, "2021-10-25T22:30:34Z", [0.0, 0.93, 0.06, 0.01, 0.0], ""], [691, "2021-10-25T21:06:08Z", [0.0, 0.8, 0.2, 0.0, 0.0], ""], [67312, "2021-10-25T12:02:35Z", [0.0, 0.77, 0.23, 0.0, 0.0], ""], [88452, "2021-10-24T19:41:52Z", [0.0, 0.69, 0.26, 0.05, 0.0], ""], [87889, "2021-10-24T13:06:40Z", [0.0, 0.92, 0.08, 0.0, 0.0], ""], [99780, "2021-10-24T10:34:53Z", [0.0, 0.95, 0.05, 0.0, 0.0], "going off the same politico article as everyone else. should have trusted my gut i guess! i'd like to see independent verification of politico's reporting by another outlet."], [86607, "2021-10-23T16:48:03Z", [0.0, 0.92, 0.08, 0.0, 0.0], "https://www.politico.com/news/2021/10/19/novavax-vaccine-rush-process-global-campaign-516298 Continued Novavax problems and not much time left. No pressure exists on the FDA to accelerate any new vaccine candidates"], [67312, "2021-10-22T08:11:42Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [55987, "2021-10-21T15:25:30Z", [0.0, 0.76, 0.24, 0.0, 0.0], ""], [96828, "2021-10-21T07:27:46Z", [0.0, 0.9, 0.09, 0.01, 0.0], ""], [34959, "2021-10-21T04:59:38Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [94872, "2021-10-20T20:58:42Z", [0.0, 0.85, 0.15, 0.0, 0.0], ""], [94872, "2021-10-20T20:57:41Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [13086, "2021-10-20T18:48:34Z", [0.0, 0.95, 0.04, 0.01, 0.0], ""], [13086, "2021-10-20T18:47:16Z", [0.0, 0.91, 0.08, 0.01, 0.0], "There is one meeting scheduled on 26th October for the Vaccine Advisory Committee for 'Discussing Data for Pfizer COVID-19 Vaccine for Children 5-11', which would not count in this circumstance.\nThis would only leave about 2 months remaining to move another vaccine(s) through the remaining process for EUA.\nSee this link for the pathway process for EUA  https://www.fda.gov/media/143890/download\n"], [691, "2021-10-20T17:50:12Z", [0.0, 0.72, 0.28, 0.0, 0.0], ""], [55987, "2021-10-20T16:11:31Z", [0.0, 0.65, 0.35, 0.0, 0.0], ""], [95503, "2021-10-20T09:55:27Z", [0.0, 0.63, 0.35, 0.02, 0.0], ""], [101394, "2021-10-20T02:57:42Z", [0.0, 0.99, 0.01, 0.0, 0.0], "novavax :/ @belikewater "], [99943, "2021-10-20T01:32:14Z", [0.0, 0.99, 0.01, 0.0, 0.0], "I think I'm going to have the worst score on this question out of all questions I've forecast so far! Absolute Brier bomb and painful lesson."], [99943, "2021-10-20T01:23:46Z", [0.0, 0.98, 0.01, 0.01, 0.0], "Novavax is likely out of the running for 2021:\n\"the company\u2019s issues are more concerning than previously understood, according to two of the people with direct knowledge of the matter.\"\n\"it is generally understood that each vaccine batch should reach at least 90 percent. The company has struggled to attain anywhere close to that, one of the people with direct knowledge of the situation said. Another person familiar with the company\u2019s manufacturing process said Novavax has recently shown purity levels hovering around 70 percent.\"\n\"In a statement, Novavax Senior Vice President of Investor Relations and Corporate Affairs Silvia Taylor told POLITICO that the company\u2019s analytical testing methods have been \u201cvalidated\u201d \u2014 but did not answer questions about whether the FDA had signed off on them. The company still plans on filing an emergency use authorization by the end of the year, Taylor said.\"\n\"Novavax \u2014 which has never produced a vaccine before \u2014 declined to answer specific questions about its product\u2019s purity levels and whether it had been successful in addressing its longstanding manufacturing issues.\"\n\"U.S. officials working with the company are not as confident, according to three people with knowledge of the matter. Novavax\u2019s manufacturing problems are seen as far more difficult to fix than the sanitary and design concerns that halted production of J&J\u2019s vaccine at the Emergent plant earlier this year, those people said.\"\n\"four people with knowledge of the matter say U.S. officials now no longer expect the company to win FDA sign-off on the vaccine until next year at the earliest.\"\nhttps://www.politico.com/news/2021/10/19/novavax-vaccine-rush-process-global-campaign-516298"], [99943, "2021-10-20T01:15:40Z", [0.0, 0.85, 0.14, 0.01, 0.0], "Time is running out, and Novavax is still talking about submitting an application by the end of the year. And there are apparently doubts about whether the FDA will sign off on its manufacturing processes. Not looking likely for the end of the year. I was too optimistic for this question, which has turned into a Brier bomb for me."], [530, "2021-10-19T22:11:12Z", [0.0, 0.67, 0.28, 0.05, 0.0], ""], [87889, "2021-10-19T18:02:24Z", [0.0, 0.7, 0.3, 0.0, 0.0], ""], [55987, "2021-10-19T15:50:50Z", [0.0, 0.56, 0.44, 0.0, 0.0], ""], [101394, "2021-10-18T05:09:48Z", [0.0, 0.57, 0.43, 0.0, 0.0], ""], [96828, "2021-10-17T23:58:59Z", [0.0, 0.66, 0.33, 0.01, 0.0], ""], [96828, "2021-10-17T23:57:17Z", [0.0, 0.64, 0.34, 0.02, 0.0], ""], [67312, "2021-10-17T23:49:30Z", [0.0, 0.65, 0.35, 0.0, 0.0], ""], [99780, "2021-10-15T13:05:36Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [20156, "2021-10-15T05:40:04Z", [0.0, 0.64, 0.36, 0.0, 0.0], ""], [55987, "2021-10-14T16:20:27Z", [0.0, 0.5, 0.5, 0.0, 0.0], ""], [94872, "2021-10-13T22:52:27Z", [0.0, 0.58, 0.4, 0.02, 0.0], ""], [96828, "2021-10-13T12:41:27Z", [0.0, 0.6, 0.38, 0.02, 0.0], "Paging Novavax followers. What do y'all think about the Phase 3 data and the EUA goal? Post-mortem: Imagine if this scenario had rendered out to a full approval."], [96828, "2021-10-13T12:40:10Z", [0.0, 0.64, 0.34, 0.02, 0.0], ""], [99943, "2021-10-12T23:46:57Z", [0.0, 0.19, 0.79, 0.02, 0.0], ""], [83135, "2021-10-12T23:00:04Z", [0.0, 0.3, 0.6, 0.1, 0.0], ""], [83135, "2021-10-12T22:58:48Z", [0.0, 0.0, 0.6, 0.4, 0.0], ""], [99943, "2021-10-12T14:43:00Z", [0.0, 0.2, 0.8, 0.0, 0.0], ""], [99943, "2021-10-12T14:37:28Z", [0.0, 0.25, 0.75, 0.0, 0.0], "Novavax Phase 3 results are finally out, and good! They came out yesterday. No word on exactly when an EUA application will be submitted, but I am optimistic that it will be soon. I'm fairly certain the FDA will approve their submission, so imo, it's mainly about whether they submit an EUA application in time for authorization by the end of the year.\nhttps://twitter.com/Novavax/status/1447571753769832455\nAnd I have zero probabilities on higher numbers because I don't think any other vaccine is in the running at this point. Medicago would be the only possibility, but we haven't heard any statement from them about going for FDA authorization or approval at all."], [96828, "2021-10-12T10:41:30Z", [0.0, 0.85, 0.13, 0.02, 0.0], ""], [29054, "2021-10-11T17:59:28Z", [0.0, 0.88, 0.12, 0.0, 0.0], ""], [55987, "2021-10-11T15:56:40Z", [0.0, 0.86, 0.14, 0.0, 0.0], ""], [34959, "2021-10-11T15:02:13Z", [0.0, 0.67, 0.32, 0.01, 0.0], ""], [87827, "2021-10-11T14:49:51Z", [0.01, 0.43, 0.44, 0.12, 0.0], ""], [99780, "2021-10-11T14:46:54Z", [0.0, 0.82, 0.18, 0.0, 0.0], ""], [99943, "2021-10-11T14:09:42Z", [0.0, 0.6, 0.4, 0.0, 0.0], "Time is running out for an EUA application to be submitted in time to be approved. I haven't given up on Novavax yet, but I have given up on Medicago."], [94872, "2021-10-11T06:05:04Z", [0.0, 0.65, 0.33, 0.02, 0.0], ""], [96828, "2021-10-10T20:22:27Z", [0.0, 0.84, 0.14, 0.02, 0.0], ""], [96828, "2021-10-10T20:20:16Z", [0.0, 0.81, 0.18, 0.01, 0.0], ""], [96828, "2021-10-10T00:42:02Z", [0.0, 0.87, 0.12, 0.01, 0.0], ""], [530, "2021-10-07T22:19:42Z", [0.0, 0.52, 0.43, 0.05, 0.0], ""], [99993, "2021-10-07T21:20:09Z", [0.0, 0.83, 0.15, 0.02, 0.0], ""], [73687, "2021-10-07T02:00:39Z", [0.0, 0.73, 0.26, 0.01, 0.0], ""], [101499, "2021-10-06T20:23:20Z", [0.0, 0.91, 0.09, 0.0, 0.0], ""], [88452, "2021-10-05T18:53:24Z", [0.0, 0.13, 0.71, 0.16, 0.0], ""], [691, "2021-10-05T15:39:30Z", [0.0, 0.7, 0.3, 0.0, 0.0], ""], [55987, "2021-10-04T16:07:14Z", [0.0, 0.78, 0.22, 0.0, 0.0], ""], [87827, "2021-10-04T11:27:24Z", [0.01, 0.43, 0.44, 0.12, 0.0], ""], [102847, "2021-10-03T15:47:57Z", [0.0, 0.48, 0.52, 0.0, 0.0], ""], [88452, "2021-10-03T13:28:12Z", [0.0, 0.22, 0.69, 0.09, 0.0], ""], [691, "2021-10-02T17:38:59Z", [0.0, 0.64, 0.36, 0.0, 0.0], ""], [14826, "2021-10-02T13:20:19Z", [0.0, 0.6, 0.4, 0.0, 0.0], ""], [102774, "2021-10-02T12:36:34Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [94872, "2021-10-02T02:16:50Z", [0.0, 0.6, 0.38, 0.02, 0.0], ""], [55987, "2021-10-01T15:59:32Z", [0.0, 0.6, 0.4, 0.0, 0.0], ""], [99780, "2021-09-30T13:20:12Z", [0.0, 0.66, 0.33, 0.01, 0.0], "Novovax has applied for WHO emergency use auth: https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-applies-who-emergency-listing-covid-19-vaccine-2021-09-23/ The article says they are targeting middle and low-income countries, suggesting they are not making a priority of getting FDA approval. They are also facing production issues so I suspect they will continue to delay a focus on the US market."], [96847, "2021-09-30T03:51:42Z", [0.29, 0.55, 0.14, 0.02, 0.0], ""], [99943, "2021-09-29T03:24:06Z", [0.0, 0.43, 0.56, 0.01, 0.0], ""], [99943, "2021-09-29T02:40:55Z", [0.0, 0.41, 0.56, 0.03, 0.0], "Novavax and perhaps Medicago are the only possibilities left."], [96828, "2021-09-29T02:23:29Z", [0.0, 0.65, 0.34, 0.01, 0.0], "Ticking up just a bit but still doubting going all the way to 3 as my final answer due to the discussion here: https://www.gjopen.com/comments/1336881 Thank you @ifrancis and @belikewater as usual."], [530, "2021-09-28T22:01:37Z", [0.0, 0.52, 0.43, 0.05, 0.0], ""], [55987, "2021-09-28T15:22:47Z", [0.0, 0.39, 0.61, 0.0, 0.0], ""], [99943, "2021-09-28T15:03:45Z", [0.0, 0.3, 0.6, 0.1, 0.0], "The Sanofi mRNA vaccine is out of the picture. (Not that it was really that much in the running, but it is now formally out.)\nIt also looks like the Sanofi/GSK protein vaccine is very likely out for the forecast period, as companies seem to be waiting for completion of Phase 3 trials to apply for an EUA at this point.\n\"[Sanofi] plans to push forward on production of a recombinant protein Covid vaccine, work it is doing in collaboration with GSK. ...\nSanofi hopes to have readouts by the end of this year on the Phase 3 trial of its recombinant vaccine as a primary Covid vaccine, as well as results of ongoing trials testing the Sanofi jab as a booster for other vaccines.\"\nhttps://www.statnews.com/2021/09/28/with-positive-data-on-mrna-covid-vaccine-sanofi-sets-its-sights-on-other-pathogens/ So that leaves Novavax, perhaps Medicago (no news on that front), and a remote possibility of AZ. Maybe I'm wrong, but I do think it's likely that at least one more will be authorized by the end of the year. Later edit: thanks to @ifrancis, who linked to an article indicating that AZ is likely filing for full approval and is in the process of preparing their application. (It had seemed less certain to me until now.) That means that AZ is out for this forecast. Even if they were to get an EUA application in by the \"end of the year,\" that likely wouldn't be soon enough for the FDA to act on it in the forecast period.\n\"The drugmaker now expects to submit its FDA application by the end of this year. The British pharma is skipping the emergency use authorization process and has been eying a full U.S. approval. As AstraZeneca CEO Pascal Soriot pointed out on a call Thursday, the application package for a full approval is much larger than an EUA dossier. It\u2019s typical for a drugmaker to take six or seven years to prepare for an FDA filing after wrapping up phase 3 testing, he noted.\"\nhttps://www.fiercepharma.com/pharma/astrazeneca-weighs-options-for-covid-vaccine-business-as-fda-filing-drags"], [95503, "2021-09-28T07:51:23Z", [0.0, 0.57, 0.4, 0.03, 0.0], ""], [20156, "2021-09-28T07:07:37Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [14266, "2021-09-28T03:55:19Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [87342, "2021-09-27T07:49:29Z", [0.0, 0.46, 0.44, 0.05, 0.05], ""], [94872, "2021-09-27T03:16:05Z", [0.0, 0.57, 0.4, 0.03, 0.0], ""], [99780, "2021-09-25T20:45:20Z", [0.0, 0.64, 0.35, 0.01, 0.0], ""], [691, "2021-09-25T15:48:30Z", [0.0, 0.6, 0.39, 0.01, 0.0], ""], [24440, "2021-09-24T18:24:58Z", [0.0, 0.9, 0.09, 0.01, 0.0], "With no additional FDA filings in the last month and the \"fastest approval in FDA history\" having taken four months to review, it seems increasingly unlikely that additional vaccines with be approved in 2021. So, adjusting my forecast to reflect most likely outcome is no additional vaccine approvals this year, with smaller chance that Astra-Zeneca or Novavax decide to file."], [98345, "2021-09-24T02:17:10Z", [0.0, 0.7, 0.3, 0.0, 0.0], ""], [95503, "2021-09-23T15:47:12Z", [0.0, 0.35, 0.5, 0.14, 0.01], ""], [101394, "2021-09-23T04:48:11Z", [0.0, 0.55, 0.43, 0.02, 0.0], ""], [85522, "2021-09-22T13:48:47Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [530, "2021-09-21T19:01:37Z", [0.0, 0.5, 0.45, 0.05, 0.0], ""], [24146, "2021-09-21T13:18:12Z", [0.9, 0.1, 0.0, 0.0, 0.0], ""], [84880, "2021-09-20T21:40:07Z", [0.0, 0.55, 0.44, 0.01, 0.0], ""], [55987, "2021-09-20T18:25:37Z", [0.0, 0.17, 0.82, 0.01, 0.0], ""], [88452, "2021-09-19T10:35:21Z", [0.0, 0.47, 0.47, 0.06, 0.0], ""], [691, "2021-09-16T16:25:25Z", [0.0, 0.55, 0.43, 0.02, 0.0], ""], [34959, "2021-09-14T15:29:48Z", [0.0, 0.5, 0.46, 0.04, 0.0], "Shuffling down with time,"], [55987, "2021-09-14T15:18:28Z", [0.0, 0.27, 0.72, 0.01, 0.0], "Still confident that Novavax will submit an EUA next month, which I expect to get approved in November as the winter wave hits. "], [99780, "2021-09-14T15:18:04Z", [0.0, 0.63, 0.36, 0.01, 0.0], "Local news in Chattanooga TN claims Novovax is \"getting ready\" to seek \"full approval\" .... in the \"coming months.\" https://www.wdef.com/novavax-vaccine-getting-ready-to-apply-for-full-approval/  Very weird, I wouldn't give it much credence. Nobody from the company is even quoted. Meanwhile time keeps marching."], [530, "2021-09-14T13:51:27Z", [0.0, 0.5, 0.45, 0.05, 0.0], ""], [99943, "2021-09-13T22:51:26Z", [0.0, 0.35, 0.45, 0.2, 0.0], "All companies realistically need to file at least by the end of November for there to be a chance at an EUA. The time window is narrowing.\n3 currently authorized.\nMaybe, in order of what I think is the likelihood of FDA authorization/approval happening in 2021:\n* Novavax (EUA application to be filed in 4th quarter)\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA authorization/approval will likely be sought.)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results; no news for a while)\n* Sanofi mRNA\n* AZ (will likely apply for full approval directly; almost certainly wouldn't get approval by the end of 2021; reportedly considering getting out of Covid vaccine business)\nI think Novavax and Sanofi/GSK are most likely but not shoe-ins. I think seeing at least one more authorization by the end of the year is likely."], [102545, "2021-09-13T19:28:58Z", [0.65, 0.18, 0.17, 0.0, 0.0], ""], [96828, "2021-09-13T11:20:02Z", [0.0, 0.64, 0.35, 0.01, 0.0], "Same philosophy so same general forecast but honing in toward the respective bins."], [94872, "2021-09-13T07:52:35Z", [0.0, 0.53, 0.42, 0.05, 0.0], ""], [86607, "2021-09-12T23:26:10Z", [0.01, 0.77, 0.21, 0.01, 0.0], ""], [99943, "2021-09-11T03:15:08Z", [0.0, 0.32, 0.45, 0.2, 0.03], ""], [422, "2021-09-10T18:33:28Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [87827, "2021-09-10T13:11:26Z", [0.01, 0.43, 0.44, 0.12, 0.0], "Continuing to drop as time passes with no news. Astrazeneca (10%, down 10 as it really doesn't seem like they have much interest or urgency in applying in the US)\nNovavax (40%, down 10 on passage of time)\nSanofi/GSK (20%, down 10 on passage of time)\nOther (1%, same as last) Calculator: https://docs.google.com/spreadsheets/d/1BEukXZ_IOMEESxaMPD216qugBo7kppVRbXuqp-pPmNg/edit?usp=sharing"], [73687, "2021-09-10T02:48:05Z", [0.0, 0.6, 0.39, 0.01, 0.0], ""], [94872, "2021-09-09T23:49:55Z", [0.0, 0.51, 0.43, 0.06, 0.0], ""], [22689, "2021-09-09T17:58:05Z", [0.0, 0.7, 0.3, 0.0, 0.0], ""], [96828, "2021-09-09T07:07:55Z", [0.0, 0.63, 0.28, 0.08, 0.01], ""], [59836, "2021-09-08T18:09:02Z", [0.0, 0.33, 0.33, 0.32, 0.02], "May be a little late in adjusting my prediction. Going even for 4 and 5 due to Sanofi saying the vaccine won't be available in France for a few months (and the FDA is usually much slower in authorizing). Novavax has also said it will go for full approval instead of authorization, so it's kinda looking shaky whether those 2 can meet the deadline. Nothing from Medicago for a while but I'm going to play it cautious and say they might have some delays."], [55987, "2021-09-08T15:34:35Z", [0.0, 0.32, 0.63, 0.05, 0.0], ""], [101989, "2021-09-08T12:27:07Z", [0.0, 0.55, 0.45, 0.0, 0.0], ""], [530, "2021-09-07T13:25:28Z", [0.0, 0.49, 0.45, 0.06, 0.0], ""], [67312, "2021-09-07T04:29:35Z", [0.0, 0.79, 0.2, 0.01, 0.0], "I think it comes down to whether Novavax will apply before December (which is likely) and whether the FDA will approve it before the 31st if they do (which is not). The other 1% represents my delusion that the FDA will concede that Sputnik is the safest and most effective vaccine on the planet. I know they'll never do that, but the prospect amuses me."], [101394, "2021-09-04T03:07:50Z", [0.0, 0.46, 0.47, 0.07, 0.0], "https://www.gjopen.com/comments/1324792 great discussion here"], [99943, "2021-09-04T02:34:51Z", [0.0, 0.2, 0.46, 0.31, 0.03], ""], [99780, "2021-09-03T08:31:12Z", [0.0, 0.61, 0.38, 0.01, 0.0], ""], [530, "2021-09-02T16:55:35Z", [0.0, 0.48, 0.46, 0.06, 0.0], ""], [55987, "2021-09-02T15:46:55Z", [0.0, 0.25, 0.7, 0.05, 0.0], ""], [96828, "2021-09-01T12:51:08Z", [0.0, 0.6, 0.3, 0.09, 0.01], "Back down because the Forecast prediction market app has 22 forecasters giving Novavax a 90%+ probability of yes. I may have to climb down the ladder if this trend holds or if new evidence warrants."], [691, "2021-08-30T19:54:27Z", [0.0, 0.52, 0.45, 0.03, 0.0], ""], [87342, "2021-08-30T11:26:03Z", [0.0, 0.31, 0.41, 0.23, 0.05], ""], [88452, "2021-08-30T01:10:04Z", [0.0, 0.22, 0.51, 0.27, 0.0], ""], [94872, "2021-08-29T06:19:23Z", [0.0, 0.49, 0.44, 0.07, 0.0], ""], [96828, "2021-08-29T00:18:31Z", [0.0, 0.65, 0.26, 0.08, 0.01], ""], [691, "2021-08-28T19:16:13Z", [0.0, 0.52, 0.44, 0.04, 0.0], ""], [34959, "2021-08-28T14:31:29Z", [0.0, 0.49, 0.42, 0.09, 0.0], ""], [55987, "2021-08-27T15:23:35Z", [0.0, 0.34, 0.61, 0.05, 0.0], ""], [530, "2021-08-27T13:51:20Z", [0.0, 0.48, 0.46, 0.06, 0.0], ""], [92690, "2021-08-27T03:29:58Z", [0.0, 0.47, 0.45, 0.08, 0.0], ""], [94872, "2021-08-26T20:59:46Z", [0.0, 0.46, 0.45, 0.09, 0.0], ""], [422, "2021-08-25T20:35:28Z", [0.0, 0.99, 0.01, 0.0, 0.0], ""], [94625, "2021-08-25T12:08:21Z", [0.0, 0.8, 0.2, 0.0, 0.0], ""], [530, "2021-08-24T19:22:03Z", [0.0, 0.48, 0.46, 0.06, 0.0], ""], [96828, "2021-08-24T08:55:44Z", [0.0, 0.52, 0.33, 0.13, 0.02], ""], [96828, "2021-08-23T23:30:05Z", [0.0, 0.58, 0.3, 0.1, 0.02], ""], [99780, "2021-08-23T22:11:19Z", [0.0, 0.57, 0.42, 0.01, 0.0], "the only viable option is an EUA for Novovax and they aren't applying until \"Q4,\" I'm hedging perhaps more than I should while maintaining my belief from the beginning that the most likely outcome for 1/1/2022 is that we have just the three vaccines already approved."], [691, "2021-08-23T19:49:29Z", [0.0, 0.38, 0.48, 0.14, 0.0], ""], [53391, "2021-08-23T18:46:32Z", [0.0, 0.9, 0.1, 0.0, 0.0], "Pfizer nas full approval whjch means EUA for anything in this categiry is not going to happen. So others need to get full approval, which takes normally more than the 4 months remaining in this question."], [24440, "2021-08-23T16:59:28Z", [0.0, 0.7, 0.25, 0.04, 0.01], "Updating forecast.  FDA has either approved (EUA or full) three vaccines already:  Pfizer, Moderna, and J&J.\nBased on approval in the EU already, two most likely candidates to file with the FDA are AstraZeneca in Q3 [1] and Novavax in Q4 [2]. Other candidates seem unlikely to seek US approval. The full approval of the Pfizer vaccine took four months, the \"fastest vaccine approval in FDA history' [3]. So, AstraZeneca seems  possible, with Novavax  increasingly unlikely to get approval by year end. [1] https://fortune.com/2021/07/29/astrazeneca-fda-approval-covid-vaccine-us/\n[2] https://www.cnbc.com/2021/08/05/novavax-covid-vaccine-fda-emergency-use-submission-delayed-to-q4.html\n[3] https://www.bbc.com/news/world-us-canada-58309254"], [96828, "2021-08-23T14:18:18Z", [0.01, 0.56, 0.3, 0.1, 0.03], "Pending clarification, small bump in 2 or fewer juuuuuust in case a full approval wouldn't count. I'm pretty sure it would still count as an approved vaccine. Feels weird to come up from 0% and become uncertain again... at 1%. It would be fun to see a game where assigning a 0% or 100% probability to a bin would disqualify you from continuing to update the forecast. So in other words if you are 0% sure something will not happen but change your mind a teeny-weeny bit to 1%, this would not be possible."], [96828, "2021-08-23T13:12:27Z", [0.0, 0.57, 0.3, 0.1, 0.03], ""], [96828, "2021-08-23T00:34:10Z", [0.0, 0.52, 0.37, 0.09, 0.02], ""], [102307, "2021-08-22T12:06:47Z", [0.01, 0.6, 0.33, 0.05, 0.01], ""], [98345, "2021-08-21T18:10:46Z", [0.0, 0.5, 0.45, 0.05, 0.0], ""], [55987, "2021-08-20T21:41:34Z", [0.0, 0.29, 0.62, 0.09, 0.0], ""], [94872, "2021-08-20T01:09:52Z", [0.0, 0.43, 0.48, 0.09, 0.0], ""], [530, "2021-08-19T17:06:41Z", [0.0, 0.46, 0.48, 0.06, 0.0], ""], [34959, "2021-08-19T14:45:35Z", [0.0, 0.36, 0.48, 0.16, 0.0], ""], [20156, "2021-08-19T09:12:24Z", [0.0, 0.48, 0.46, 0.06, 0.0], ""], [99943, "2021-08-19T00:50:32Z", [0.0, 0.15, 0.46, 0.34, 0.05], ""], [84880, "2021-08-17T19:19:07Z", [0.0, 0.38, 0.49, 0.13, 0.0], ""], [101989, "2021-08-17T19:06:40Z", [0.0, 0.5, 0.5, 0.0, 0.0], ""], [87827, "2021-08-17T13:30:07Z", [0.01, 0.28, 0.47, 0.22, 0.02], "Hedging toward the crowd, lowering my probabilities as follows: Astrazeneca (20%, down 15 on the article shared by @SamtheSamurai : https://www.gjopen.com/comments/1319010)\nNovavax (50%, down 10 because they've delayed multiple times: https://archive.is/KRw3z)\nSanofi/GSK (30%, down 10 based on the delays the other two have seen, might mean delays for Sanofi are also likely)\nOther (1%, down 4) Probability calculator: https://docs.google.com/spreadsheets/d/1BEukXZ_IOMEESxaMPD216qugBo7kppVRbXuqp-pPmNg/edit?usp=sharing"], [94872, "2021-08-17T01:55:31Z", [0.0, 0.41, 0.47, 0.12, 0.0], ""], [34815, "2021-08-16T04:24:24Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [95503, "2021-08-15T17:46:09Z", [0.0, 0.41, 0.48, 0.1, 0.01], ""], [53382, "2021-08-13T13:24:40Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [96828, "2021-08-13T12:39:02Z", [0.0, 0.5, 0.37, 0.11, 0.02], ""], [691, "2021-08-12T18:08:52Z", [0.0, 0.36, 0.48, 0.16, 0.0], ""], [61598, "2021-08-12T06:33:30Z", [0.0, 0.4, 0.45, 0.15, 0.0], ""], [95944, "2021-08-11T12:57:37Z", [0.05, 0.08, 0.19, 0.33, 0.35], ""], [94872, "2021-08-11T05:34:03Z", [0.0, 0.39, 0.45, 0.16, 0.0], ""], [95503, "2021-08-10T21:08:26Z", [0.0, 0.35, 0.48, 0.15, 0.02], ""], [99993, "2021-08-10T19:37:29Z", [0.0, 0.75, 0.2, 0.05, 0.0], ""], [92331, "2021-08-10T18:36:30Z", [0.1, 0.85, 0.05, 0.0, 0.0], ""], [55987, "2021-08-10T15:39:14Z", [0.0, 0.25, 0.65, 0.1, 0.0], ""], [530, "2021-08-10T13:48:22Z", [0.0, 0.44, 0.44, 0.11, 0.01], ""], [94872, "2021-08-10T05:18:09Z", [0.0, 0.34, 0.47, 0.18, 0.01], ""], [14266, "2021-08-10T04:16:56Z", [0.0, 0.36, 0.5, 0.14, 0.0], ""], [94000, "2021-08-10T03:09:37Z", [0.0, 0.85, 0.1, 0.04, 0.01], ""], [59836, "2021-08-09T23:50:47Z", [0.0, 0.01, 0.02, 0.42, 0.55], "Decreasing for 6 on the news that AstraZeneca is no longer prioritizing approval from the FDA. Source: https://fortune.com/2021/07/29/astrazeneca-fda-approval-covid-vaccine-us/ "], [422, "2021-08-09T14:29:15Z", [0.0, 0.9, 0.1, 0.0, 0.0], ""], [99943, "2021-08-08T19:50:50Z", [0.0, 0.15, 0.42, 0.38, 0.05], "Currently authorized:\n* Pfizer\n* Moderna\n* J&J Maybe, in order of what I think is the likelihood of FDA authorization/approval happening in 2021:\n* Novavax (EUA application to be filed in 4th quarter)\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA authorization/approval will likely be sought.)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results; no news for a while)\n* Sanofi mRNA\n* AZ (might apply for full approval directly; might not get approval by the end of 2021)"], [81555, "2021-08-08T14:55:06Z", [0.0, 0.5, 0.47, 0.03, 0.0], ""], [100596, "2021-08-08T14:12:06Z", [0.0, 0.0, 0.4, 0.6, 0.0], ""], [24146, "2021-08-08T03:37:36Z", [0.9, 0.1, 0.0, 0.0, 0.0], ""], [96828, "2021-08-07T22:45:55Z", [0.0, 0.44, 0.36, 0.16, 0.04], "My thinking is that because of the needed boosters, the FDA will approve vaccines that give them confidence that (a) one dose is enough or (b) that boosters are safe and the company has enough in supply. Imagine FDA approving a vaccine where there's just going to be growing ineffectiveness to Delta and its sublineages. Imagine FDA approving a vaccine where its boosters are not proven to be safe. Or imagine FDA approving new vaccines with boosters but there is so much demand that it overwhelms the company or overwhelms any budget the government has in purchasing them. Again, I am rather ignorant on this topic so I cannot say for sure. Aug. 13 update: FDA already approving boosters. It's weird how they are doing this before fully approving of a vaccine. Which tells me a shift in priority."], [88452, "2021-08-07T14:57:45Z", [0.0, 0.0, 0.58, 0.42, 0.0], ""], [99780, "2021-08-07T07:38:11Z", [0.0, 0.59, 0.38, 0.03, 0.0], "novovax delayed"], [87827, "2021-08-06T12:04:28Z", [0.01, 0.15, 0.41, 0.34, 0.09], "Novavax delayed to 4th quarter. However on the earnings call they said the delay was a matter of weeks, not months, so guessing that means it got pushed from end of Q3 to early Q4. Still, going down 20% on Novavax approval in 2021. Astrazeneca (35%, same as last)\nNovavax (60%, down 20% from last)\nSanofi/GSK (40%, same as last)\nOther (5%, same as last) Novavax earnings call, Q&A at around 34 minutes: https://www.youtube.com/watch?v=pvjEk-gAxks Combined probabilities: https://docs.google.com/spreadsheets/d/1BEukXZ_IOMEESxaMPD216qugBo7kppVRbXuqp-pPmNg/edit?usp=sharing"], [99943, "2021-08-05T21:14:58Z", [0.0, 0.37, 0.38, 0.2, 0.05], "Revising downward... again.\n\"Novavax Inc on Thursday again delayed its timeline for seeking U.S. authorization for its two-dose COVID-19 vaccine, and the company now expects to file for its emergency use in the fourth quarter of 2021.\"\nhttps://www.reuters.com/business/healthcare-pharmaceuticals/novavax-again-delays-seeking-us-approval-covid-19-vaccine-2021-08-05/?taid=610c4ca33233bc00010b5909&utm_campaign=trueAnthem:+Trending+Content&utm_medium=trueAnthem&utm_source=twitter Currently authorized:\n* Pfizer\n* Moderna\n* J&J Maybe, in order of what I think is the likelihood of FDA authorization/approval happening in 2021:\n* Novavax (EUA application to be filed in 4th quarter)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results; no news for a while)\n* AZ (might apply for full approval directly; might not get approval by the end of 2021)\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA authorization/approval will likely be sought.)\n* Sanofi mRNA"], [98850, "2021-08-05T19:15:55Z", [0.0, 0.33, 0.57, 0.1, 0.0], "Thanks to @Emking for pointing out my lazy math on the last forecast. I have updated my expected values on vaccines and have actually done the requisite math to match my overall forecast with the below numbers - giving the \"leftover\" 1% to the chance that we have 4 approved. New Numbers are:\nModerna 99.8%\nPfizer 99.8%\nJ&J 99.8%\nAstraZeneca 15%\nNovavax 60%\nSome other 2%"], [55987, "2021-08-05T16:19:42Z", [0.0, 0.21, 0.67, 0.12, 0.0], "Reassessing discrete probabilities as follows:  Moderna 99%\nPfizer 99%\nJ&J 99%\nNovavax 75%\nAstraZeneca 15%\nother 1% This mostly reflects the recent news of Novavax expansion in the EU (increasing my assumption that they will get an EUA from the FDA this fall) and the apparent pessimism of AZ in the FDA process."], [96828, "2021-08-05T11:28:07Z", [0.0, 0.36, 0.34, 0.24, 0.06], ""], [94872, "2021-08-05T05:45:48Z", [0.0, 0.3, 0.5, 0.18, 0.02], ""], [98850, "2021-08-04T14:18:47Z", [0.0, 0.51, 0.46, 0.03, 0.0], "Here are my old expectations, but updated a bit. I'd be absolutely flabbergasted if the FDA rescended approval for the shots that have already proven effective at fighting this. Novavax seems ready to file their paperwork and MAY receive emergency authorization or even full approval by year end because their vaccine is being proven against the current variants instead of old hat - they also only need fridge temps and have more mild side effects. AZ seems determined to not file any paperwork until later this year and there's no scientific reason for the FDA to rush that through the process so I'm downgrading their likelihood of authorization. Moderna 99%\nPfizer 99%\nJ&J 99%\nAstraZeneca 35%\nNovavax 60%\nSome other 2%"], [101989, "2021-08-04T07:24:15Z", [0.0, 0.25, 0.7, 0.05, 0.0], "There are currently 3 approved for emergency use (Pfizer, Moderna, J&J). No reason to assume that these 3 won't continue to be approved (either for emergency use or as full approval).\nNovavax will likely submit for emergency use in Q3, and given its trial results should be likely to be approved in Q4.\nAstraZeneca doesn't seem on track to be approved in 2021 (likely to submit for full approval (not emergency) towards the end of the year, the full approval will probably take more time).\nNo other promising candidates. "], [530, "2021-08-03T15:52:32Z", [0.0, 0.15, 0.44, 0.4, 0.01], ""], [84880, "2021-08-02T20:06:35Z", [0.0, 0.15, 0.55, 0.29, 0.01], ""], [55987, "2021-08-02T15:20:22Z", [0.0, 0.48, 0.48, 0.03, 0.01], "It seems that the AZ application for full approval isn't even in yet, while they aren't even trying for an EUA. I'm reducing the chances they get approval/authorization before the end of the year. NovaVax, on the other hand, looks more promising to get an EAU in Nov/Dec (especially if there is another flair up in the colder months). I still don't see any others that look on pace. "], [691, "2021-08-01T15:31:25Z", [0.0, 0.08, 0.6, 0.32, 0.0], ""], [95503, "2021-07-31T13:33:34Z", [0.0, 0.3, 0.48, 0.2, 0.02], ""], [95503, "2021-07-31T13:33:13Z", [0.0, 0.2, 0.46, 0.32, 0.02], ""], [14266, "2021-07-31T05:10:34Z", [0.0, 0.26, 0.56, 0.18, 0.0], ""], [94872, "2021-07-30T08:46:57Z", [0.0, 0.3, 0.47, 0.21, 0.02], ""], [34959, "2021-07-30T04:05:42Z", [0.0, 0.3, 0.45, 0.24, 0.01], ""], [87889, "2021-07-29T23:22:21Z", [0.0, 0.47, 0.32, 0.2, 0.01], ""], [49082, "2021-07-29T19:46:23Z", [0.0, 0.12, 0.81, 0.07, 0.0], ""], [53382, "2021-07-29T18:33:25Z", [0.65, 0.35, 0.0, 0.0, 0.0], ""], [99741, "2021-07-29T17:48:19Z", [0.05, 0.2, 0.25, 0.4, 0.1], "Pfizer, Moderna, JnJ plus probably Novavax and Astrazeneca."], [55987, "2021-07-29T15:47:58Z", [0.0, 0.48, 0.36, 0.15, 0.01], ""], [87342, "2021-07-29T08:09:36Z", [0.0, 0.25, 0.42, 0.28, 0.05], ""], [96828, "2021-07-27T21:56:14Z", [0.0, 0.41, 0.39, 0.19, 0.01], ""], [530, "2021-07-27T20:41:12Z", [0.0, 0.15, 0.44, 0.4, 0.01], ""], [98850, "2021-07-27T18:14:57Z", [0.29, 0.6, 0.09, 0.02, 0.0], "Looks like the FDA is probably going to get full Pfizer approval by the end of the year. We might also see Moderna get full approval as well."], [102048, "2021-07-27T14:23:42Z", [0.0, 0.47, 0.45, 0.08, 0.0], "Based on the UK results coming down in respect to relatively high vaccination rate, I suspect that the only addition would be Novavax given recent stock market interest or the slightly more likely scenario of \"carry on as usual\".  The plan being to continue to improve existing vaccination rates based on a tried and tested approach, with global rates still low, and countries will start to get more interested in collecting available surplus stocks, meaning US will likely need to continue with existing approach.  (unless as discussed below boosters are considered independent new vaccines rather than modified vaccines."], [53391, "2021-07-27T13:09:56Z", [0.0, 0.8, 0.2, 0.0, 0.0], "THe geniuses at GJ anticipated the booster shots in their note to the question dated 14 May.  Booster shots would seem to fall into the category that the clarification describes, a similar manufacturing process with a slight modification to address a variant.  So i now go back to my previous probabilities.  There are 3 vaccines approved for EUA and none of the ones in development offer a substantial benefit over the existing 3."], [96828, "2021-07-27T07:58:36Z", [0.0, 0.27, 0.45, 0.26, 0.02], ""], [88452, "2021-07-27T04:55:40Z", [0.0, 0.0, 0.0, 1.0, 0.0], ""], [101585, "2021-07-25T13:31:57Z", [0.0, 0.0, 0.0, 0.0, 1.0], ""], [53391, "2021-07-24T17:45:24Z", [0.0, 0.0, 0.2, 0.6, 0.2], ""], [53391, "2021-07-24T13:13:02Z", [0.0, 0.0, 0.8, 0.2, 0.0], "Pfizer covid booster requires an EUA. So it would be a new vaccine approval. That would make 4. I kick myself for not realizing a booster is not the same recipe as the vaccine"], [87827, "2021-07-24T05:39:37Z", [0.01, 0.07, 0.39, 0.4, 0.13], "Hedging toward the crowd a bit and being more pessimistic on Astrazeneca and Sanofi, Astrazeneca because it doesn't seem like there's any urgency happening and if they apply for full approval that may take a while and Sanofi because their data might get delayed or pushed to early next year, or their data could come back with poor results. Now I'm at the following: Astrazeneca (35%, down 15% from my last)\nNovavax (80%, same as last)\nSanofi/GSK (40%, down 10% from last)\nOther (5%, down 5% from last) Combined probability math: https://docs.google.com/spreadsheets/d/1BEukXZ_IOMEESxaMPD216qugBo7kppVRbXuqp-pPmNg/edit?usp=sharing"], [96828, "2021-07-24T00:26:51Z", [0.0, 0.66, 0.22, 0.1, 0.02], ""], [96828, "2021-07-24T00:14:27Z", [0.0, 0.61, 0.25, 0.12, 0.02], "My overall thinking relates to recent news about the Delta variant. I'm going to wait 30 days or so to see where things trend. Overall, this has been my true and honest belief."], [99780, "2021-07-23T17:46:04Z", [0.0, 0.56, 0.38, 0.06, 0.0], "I have no new information to influence my forecast but a very slight change in thinking. Vaccine hesitancy remains a large problem in the US. Perhaps granting EUA to a fourth vaccine (most likely Novovax) that would have obviously earned it last winter, had it been a first mover, would help enforce the narrative that the vaccines are highly safe and effective. As a bit of irrelevant editorializing: the fact that over 150m Americans and a billion people globally have taken these vaccines with a negligible quantity of adverse effects and yet the FDA will not fully authorize them is outrageous. AZ should be fully approved here despite problems with their US clinical trial, it is clearly safe and effective."], [99706, "2021-07-23T14:23:35Z", [0.0, 0.15, 0.55, 0.3, 0.0], ""], [98345, "2021-07-23T02:14:18Z", [0.0, 0.41, 0.38, 0.15, 0.06], ""], [96828, "2021-07-22T23:47:50Z", [0.0, 0.22, 0.47, 0.27, 0.04], ""], [95503, "2021-07-22T12:34:38Z", [0.0, 0.18, 0.46, 0.32, 0.04], ""], [34959, "2021-07-22T08:29:30Z", [0.0, 0.08, 0.56, 0.35, 0.01], ""], [14266, "2021-07-22T04:36:39Z", [0.0, 0.26, 0.61, 0.13, 0.0], ""], [691, "2021-07-20T18:29:35Z", [0.0, 0.0, 0.68, 0.32, 0.0], ""], [55987, "2021-07-19T16:09:27Z", [0.0, 0.37, 0.41, 0.21, 0.01], "My understanding is that Astrazeneca and Novavaxx are the only options far enough in the process to possibly get FDA approval or authorization before the end of the year. My intuition is that approvals will become more difficult as the spread slows. Therefore, I want to say that the current three will remain the only three during 2021. While the crowd's optimism has pulled me too high, I'm starting to pull back."], [55987, "2021-07-19T15:58:50Z", [0.0, 0.13, 0.51, 0.35, 0.01], ""], [96828, "2021-07-19T11:54:07Z", [0.0, 0.4, 0.4, 0.12, 0.08], ""], [95503, "2021-07-18T21:16:54Z", [0.0, 0.18, 0.4, 0.32, 0.1], ""], [53391, "2021-07-17T10:34:44Z", [0.0, 0.8, 0.2, 0.0, 0.0], "Maintaining my 80/20 for 3 or 4 vaccines.  Novavaxx is still apossibility for EUA. BUT FDA announcing accelerated approval process for full authorization of Pfizer (which would conclude Jan 2022) calls into question if there is appetitie to do an EUA for Novavaxx. "], [94872, "2021-07-17T03:09:32Z", [0.0, 0.36, 0.44, 0.18, 0.02], ""], [99780, "2021-07-16T23:36:14Z", [0.0, 0.59, 0.35, 0.06, 0.0], "The FDA is signaling that they will not give full authorization to any vaccines under EUA until early 2022, and this is under their \u201cexpedited\u201d timeline. This any vaccine without EUA certainly will not get full authorization this year. They will have to apply for and receive EUA.  Given we have adequate supply of three highly effective vaccines, why would the FDA grant emergency use for a fourth vaccine? I have seen no adequate explanation.  The best I can imagine is that because the Novovax has as good or slightly better numbers than other two dose treatments and it is a \u201cconventional\u201d or non-mRNA based vaccine, they might grant it on an emergency basis. I will revise my prediction as soon as Novovax either files or announces their intention to do so, and/or the FDA signals whether another EUA is in the offing. "], [88098, "2021-07-16T11:19:53Z", [0.0, 0.35, 0.5, 0.15, 0.0], ""], [96828, "2021-07-16T05:59:30Z", [0.0, 0.46, 0.37, 0.14, 0.03], ""], [96828, "2021-07-16T05:26:21Z", [0.0, 0.46, 0.39, 0.14, 0.01], ""], [14266, "2021-07-16T04:13:52Z", [0.0, 0.26, 0.51, 0.23, 0.0], ""], [101216, "2021-07-15T20:59:58Z", [0.0, 0.49, 0.3, 0.16, 0.05], "updating to include a chance of J&J getting revoked "], [530, "2021-07-15T14:56:54Z", [0.0, 0.15, 0.4, 0.4, 0.05], ""], [99780, "2021-07-15T14:49:06Z", [0.0, 0.52, 0.42, 0.06, 0.0], "Still no concrete information when Novavax will apply for FDA approval, and whether they will seek EUA or not. Rumors rae they will file \"in Q3\" which could be any time between today and 30 Sept. Obv the closer they get to the end of the quarter, the less likely they will get approval in this calendar year. I maintain my prior position that the FDA will provide guidance, publicly or behind, to seek full authorization directly. I don't see any other viable option on the horizon."], [101187, "2021-07-13T15:34:59Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [101892, "2021-07-13T14:33:20Z", [0.0, 0.4, 0.35, 0.2, 0.05], "AstraZeneca could be added to the mix but the big factor is barring a need for booster shots. There have been more shots given that will be needed in the future."], [100742, "2021-07-13T12:02:55Z", [0.09, 0.65, 0.2, 0.05, 0.01], ""], [691, "2021-07-11T18:11:07Z", [0.0, 0.0, 0.57, 0.42, 0.01], ""], [55987, "2021-07-09T15:49:17Z", [0.0, 0.12, 0.47, 0.35, 0.06], ""], [691, "2021-07-09T15:44:38Z", [0.0, 0.0, 0.52, 0.47, 0.01], ""], [96828, "2021-07-07T11:46:29Z", [0.0, 0.27, 0.39, 0.28, 0.06], ""], [84880, "2021-07-06T17:57:08Z", [0.0, 0.01, 0.58, 0.4, 0.01], ""], [101793, "2021-07-06T00:06:59Z", [0.0, 0.0, 0.6, 0.3, 0.1], ""], [95503, "2021-07-05T21:06:23Z", [0.0, 0.24, 0.41, 0.27, 0.08], ""], [691, "2021-07-04T14:44:00Z", [0.0, 0.0, 0.51, 0.48, 0.01], ""], [101499, "2021-07-02T15:34:44Z", [0.0, 0.05, 0.67, 0.28, 0.0], ""], [91517, "2021-07-01T22:42:15Z", [0.0, 0.0, 0.5, 0.25, 0.25], ""], [83135, "2021-07-01T01:35:27Z", [0.0, 0.0, 0.3, 0.7, 0.0], ""], [101687, "2021-06-30T16:10:31Z", [0.0, 0.98, 0.02, 0.0, 0.0], ""], [14266, "2021-06-30T05:07:29Z", [0.0, 0.02, 0.51, 0.43, 0.04], ""], [94872, "2021-06-30T03:58:29Z", [0.0, 0.12, 0.4, 0.35, 0.13], ""], [530, "2021-06-29T15:32:17Z", [0.0, 0.0, 0.55, 0.4, 0.05], ""], [100273, "2021-06-27T13:29:06Z", [0.0, 0.0, 1.0, 0.0, 0.0], "They have no direction,  and the new strain panic has been overplayed. "], [84880, "2021-06-27T01:23:38Z", [0.0, 0.07, 0.59, 0.33, 0.01], ""], [95503, "2021-06-25T09:02:18Z", [0.0, 0.05, 0.4, 0.4, 0.15], ""], [101499, "2021-06-24T21:42:13Z", [0.0, 0.55, 0.4, 0.05, 0.0], ""], [55987, "2021-06-24T16:04:18Z", [0.0, 0.05, 0.5, 0.39, 0.06], ""], [101499, "2021-06-24T13:07:17Z", [0.0, 0.4, 0.5, 0.1, 0.0], ""], [34815, "2021-06-24T04:40:11Z", [0.0, 0.0, 1.0, 0.0, 0.0], ""], [99943, "2021-06-24T00:55:43Z", [0.0, 0.0, 0.5, 0.45, 0.05], ""], [101261, "2021-06-23T22:03:40Z", [0.0, 0.2, 0.6, 0.2, 0.0], ""], [99706, "2021-06-23T15:23:44Z", [0.0, 0.0, 0.45, 0.45, 0.1], ""], [530, "2021-06-22T14:20:29Z", [0.0, 0.0, 0.55, 0.4, 0.05], ""], [99943, "2021-06-22T14:11:44Z", [0.0, 0.0, 0.48, 0.45, 0.07], ""], [20156, "2021-06-22T10:55:24Z", [0.0, 0.0, 0.55, 0.41, 0.04], ""], [94872, "2021-06-22T04:55:04Z", [0.0, 0.13, 0.42, 0.34, 0.11], ""], [55987, "2021-06-21T20:12:31Z", [0.0, 0.12, 0.49, 0.35, 0.04], ""], [87827, "2021-06-21T15:44:34Z", [0.01, 0.04, 0.27, 0.44, 0.24], "Tweaking based on the following revised probabilities: Astrazeneca (50%, down 5% from my last)\nNovavax (80%, same as last)\nSanofi/GSK (50%, down 5% from last)\nOther (10%, down 15% from last just on perceived lack of news on others having a chance at approval) Math on combined probabilities is here: https://docs.google.com/spreadsheets/d/1BEukXZ_IOMEESxaMPD216qugBo7kppVRbXuqp-pPmNg/edit?usp=sharing"], [34959, "2021-06-21T15:03:48Z", [0.0, 0.01, 0.48, 0.48, 0.03], ""], [96828, "2021-06-21T01:24:10Z", [0.0, 0.19, 0.43, 0.3, 0.08], ""], [59836, "2021-06-20T19:49:56Z", [0.0, 0.01, 0.02, 0.3, 0.67], "Increasing for 6 or more based on the success of the Novavax, Medicago and Sanofi vaccines. Seems all have been in the works for a bit but Sanofi didn't show good results last year due to giving the wrong dosage, but that was easily fixed and 2021 trials showed good results. Astrazeneca is also still in the works, so there are a few possibilities to get to 6. Sources: https://www.forbes.com/sites/roberthart/2021/05/27/new-covid-19-vaccine-will-be-produced-this-year-as-sanofi-gsk-launch-phase-3-trial/?sh=48c5820c1240\nhttps://www.theguardian.com/business/2021/may/18/gsk-medicago-covid-vaccine-trial-sanofi\nhttps://www.npr.org/sections/health-shots/2021/06/06/1003328413/new-type-of-covid-vaccine-could-debut-soon\nhttps://www.cnn.com/2021/06/14/health/novavax-covid-19-vaccine-us-phase-3-trial-study/index.html"], [87691, "2021-06-20T04:37:50Z", [0.0, 0.0, 0.0, 1.0, 0.0], ""], [28351, "2021-06-19T23:00:34Z", [0.0, 0.0, 0.97, 0.03, 0.0], ""], [14826, "2021-06-19T15:31:58Z", [0.0, 0.24, 0.47, 0.24, 0.05], ""], [99943, "2021-06-19T04:42:36Z", [0.0, 0.0, 0.45, 0.45, 0.1], ""], [88098, "2021-06-18T02:39:08Z", [0.0, 0.25, 0.53, 0.22, 0.0], ""], [85522, "2021-06-17T16:03:22Z", [0.0, 0.0, 0.2, 0.48, 0.32], ""], [55987, "2021-06-17T15:04:11Z", [0.0, 0.14, 0.54, 0.28, 0.04], ""], [99943, "2021-06-17T14:51:51Z", [0.0, 0.0, 0.4, 0.4, 0.2], "I think authorization is very likely for the Novavax vaccine, likely for the Medicago vaccine, and possible for the AZ and Sanofi/GSK protein vaccines in 2021. Some disappointing results with recent vaccines, though. Ocugen is almost certainly out. CureVac is out, although it was never a real possibility for this question anyway. Also: \"Novavax also remains confident that by Q3 it will file EUAs to the FDA, MHRA (UK) and EMA (EU).\"\nhttps://finance.yahoo.com/news/novavax-still-compelling-covid-19-224043135.html Current yes:\n* Pfizer\n* Moderna\n* J&J Maybe, in order of what I think is the likelihood of FDA authorization/approval happening in 2021:\n* Novavax (EUA application to be filed in 3rd quarter)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results; no news for a while)\n* AZ (might apply for full approval directly; might not get approval by the end of 2021)\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA authorization/approval will likely be sought.)\n* Sanofi mRNA\n* Ocugen inactivated virus vaccine"], [530, "2021-06-17T14:13:48Z", [0.0, 0.0, 0.55, 0.4, 0.05], ""], [99780, "2021-06-17T05:16:08Z", [0.0, 0.48, 0.43, 0.08, 0.01], "Efficacy of novovax is v good, they have not decided whether to apply for emergency use. I suspect they will not because there is no justifiable case for an emergency need for a fourth vaccine when the other three are abundantly available in the US. By contrast the CureVac vaccine has only 47% efficacy and won\u2019t be approved as a result. Still no signs from AZ they are going to apply for approval. "], [22689, "2021-06-16T21:45:41Z", [0.0, 0.0, 0.5, 0.5, 0.0], ""], [691, "2021-06-16T14:02:34Z", [0.0, 0.0, 0.48, 0.51, 0.01], ""], [86784, "2021-06-16T00:04:40Z", [0.0, 0.05, 0.5, 0.3, 0.15], "In addition to the three currently approved, it looks like Novavax will likely be approved: https://www.msn.com/en-us/health/medical/another-covid-vaccine-option-here-e2-80-99s-what-we-know-about-the-novavax-shot-that-e2-80-99s-on-the-way/ar-AAL3ObA?ocid=uxbndlbing"], [94625, "2021-06-15T13:33:41Z", [0.0, 0.0, 0.05, 0.8, 0.15], ""], [88452, "2021-06-15T09:30:37Z", [0.0, 0.0, 0.0, 1.0, 0.0], ""], [96828, "2021-06-15T06:45:30Z", [0.0, 0.29, 0.38, 0.26, 0.07], ""], [34815, "2021-06-15T04:33:56Z", [0.0, 0.0, 0.0, 1.0, 0.0], ""], [691, "2021-06-14T20:07:38Z", [0.0, 0.0, 0.56, 0.44, 0.0], ""], [98345, "2021-06-13T19:08:56Z", [0.0, 0.26, 0.45, 0.2, 0.09], ""], [99943, "2021-06-13T06:02:59Z", [0.0, 0.0, 0.2, 0.46, 0.34], "Ocugen is likely out for 2021 approval. @SE_Meyer, thought you'd be interested:\n\"OCGN announced that it will submit a biologics license application (\u201cBLA\u201d) for its COVID-19 vaccine candidate, Covaxin, in the United States following the FDA's recommendation.\nThe company will no longer pursue an Emergency Use Authorization (\u201cEUA\u201d) for the vaccine candidate, and instead, will seek more formal approval for Covaxin. This might delay the launch of the vaccine in the United States.\nThe regulatory body recommended Ocugen to pursue a BLA submission instead of an EUA application for Covaxin and requested additional information and data on the same. The company believes that data from an additional clinical study will likely be necessary to support the BLA.\"\nhttps://finance.yahoo.com/news/ocugen-ocgn-file-coronavirus-vaccine-155103491.html Also: \"Novavax also remains confident that by Q3 it will file EUAs to the FDA, MHRA (UK) and EMA (EU).\"\nhttps://finance.yahoo.com/news/novavax-still-compelling-covid-19-224043135.html Current yes:\n* Pfizer\n* Moderna\n* J&J Maybe, in order of what I think is the likelihood of FDA authorization/approval happening in 2021:\n* Novavax (EUA application to be filed in 3rd quarter)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results)\n* AZ (might apply for full approval directly; might not get approval by the end of 2021)\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA authorization/approval will likely be sought.)\n* Ocugen inactivated virus vaccine\n* Sanofi mRNA\n* CureVac (will likely be approved in EU in 2021, but I don't see interest in applying for FDA approval; see, e.g., https://www.verywellhealth.com/curvac-covid-19-vaccine-5184398) I think authorization or approval is very likely for the Novavax vaccine, likely for the Medicago vaccine, and possible for AZ, Sanofi/GSK protein and/or Ocugen vaccines in 2021. I would actually put the chances of 5 or of 6 or more at the same level, but then my Brier score would be at a disadvantage if it turned out to be 5."], [33423, "2021-06-11T14:31:01Z", [0.0, 0.0, 0.2, 0.7, 0.1], ""], [54663, "2021-06-11T14:08:14Z", [0.0, 0.0, 0.5, 0.4, 0.1], ""], [99706, "2021-06-11T13:44:30Z", [0.0, 0.05, 0.4, 0.45, 0.1], ""], [55987, "2021-06-10T20:22:59Z", [0.0, 0.14, 0.54, 0.28, 0.04], ""], [95503, "2021-06-10T15:24:35Z", [0.0, 0.1, 0.45, 0.35, 0.1], ""], [78984, "2021-06-10T14:03:51Z", [0.01, 0.08, 0.21, 0.39, 0.31], ""], [94872, "2021-06-10T05:18:21Z", [0.0, 0.16, 0.42, 0.32, 0.1], ""], [22689, "2021-06-09T21:08:07Z", [0.0, 0.0, 0.8, 0.2, 0.0], ""], [100386, "2021-06-09T17:34:09Z", [0.0, 0.0, 0.1, 0.3, 0.6], ""], [81555, "2021-06-09T15:49:30Z", [0.0, 0.05, 0.47, 0.48, 0.0], ""], [530, "2021-06-09T14:16:33Z", [0.0, 0.0, 0.5, 0.45, 0.05], ""], [88098, "2021-06-09T12:03:43Z", [0.0, 0.25, 0.45, 0.25, 0.05], ""], [34959, "2021-06-09T04:22:16Z", [0.0, 0.01, 0.4, 0.55, 0.04], ""], [85522, "2021-06-08T21:28:41Z", [0.0, 0.0, 0.14, 0.43, 0.43], ""], [691, "2021-06-08T15:24:57Z", [0.0, 0.0, 0.48, 0.52, 0.0], ""], [85031, "2021-06-08T11:53:03Z", [0.0, 0.0, 0.3, 0.5, 0.2], ""], [89013, "2021-06-08T07:44:31Z", [0.0, 0.0, 0.42, 0.58, 0.0], ""], [94872, "2021-06-08T06:12:06Z", [0.0, 0.12, 0.4, 0.36, 0.12], ""], [99943, "2021-06-08T01:05:36Z", [0.0, 0.0, 0.0, 0.5, 0.5], "New article: https://www.npr.org/sections/health-shots/2021/06/06/1003328413/new-type-of-covid-vaccine-could-debut-soon?utm_source=twitter.com&utm_medium=social&utm_campaign=atc&utm_term=nprnews&utm_content=20210607\nNot much new content, but I just don't see how at least 2 more vaccines won't be authorized or approved by the end of the year. Novavax is my #1 candidate; several others could be #2 or #3. Current yes:\n* Pfizer\n* Moderna\n* J&J Maybe, in order of what I think is the likelihood of FDA authorization/approval happening in 2021:\n* Novavax (EUA application to be filed in 3rd quarter)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results)\n* AZ (might apply for full approval directly; might not get approval by the end of 2021)\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA authorization/approval will likely be sought.)\n* Ocugen inactivated virus vaccine\n* Sanofi mRNA\n* CureVac (will likely be approved in EU in 2021, but I don't see interest in applying for FDA approval; see, e.g., https://www.verywellhealth.com/curvac-covid-19-vaccine-5184398) I think authorization or approval is likely for the Novavax, Medicago and Ocugen vaccines in 2021, and AZ is possible. We could possibly even end up with 8 approved or authorized vaccines by the end of the year."], [101216, "2021-06-07T17:36:01Z", [0.0, 0.4, 0.3, 0.2, 0.1], "Obviously, 3 has to be likelihood favorite since it currently sits at that number (JJ, Moderna, Pfizer) but there are a few coming on the horizon. The FDA has, however, now adopted new policy focuses and authorizing more now sits on the backburner. One of the European or Central American vaccines may be approved in time, but it is not a priority.  "], [99943, "2021-06-06T19:32:07Z", [0.0, 0.0, 0.05, 0.45, 0.5], "Current yes:\n* Pfizer\n* Moderna\n* J&J Maybe, in order of what I think is the likelihood of FDA authorization/approval happening in 2021:\n* Novavax (EUA application to be filed in 3rd quarter)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results)\n* Ocugen inactivated virus vaccine (\"The revised guidance was issued on the same day that Ocugen Inc (NASDAQ: OCGN) had submitted its master file to FDA in anticipation of requesting a EUA for the whole-virion inactivated COVID-19 vaccine Covaxin.\" https://finance.yahoo.com/news/fda-may-not-review-covid-162123410.html )\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA authorization/approval will likely be sought.)\n* AZ (might apply for full approval directly; might not get approval by the end of 2021)\n* Sanofi mRNA\n* CureVac (will likely be approved in EU in 2021, but I don't see interest in applying for FDA approval; see, e.g., https://www.verywellhealth.com/curvac-covid-19-vaccine-5184398) Also note: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-may-not-review-new-covid-19-vaccine-eua-requests-during-pandemic-2021-05-25/\nFull approval could take some time. I'm sure it'll be expedited during the pandemic, but still, there are limits. Covaxin looks likely for 2021. \"Bharat Biotech and Ocugen expand their partnership to co-develop, supply and commercialise Covaxin, the Covid-19 vaccine from the Hyderabad-based vaccine maker, in Canada. Occugen already had the rights to commercialise Covaxin in the US. It will retain 45 per cent of the profits from sales of Covaxin in the US and Canada. Shankar Musunuri, chairman, chief executive and co-founder of Ocugen, said: \u201cAs we work towards the submission of the emergency use application in the US, we will simultaneously seek authorisation under interim order for emergency use in Canada.\u201d\"\nhttps://www.business-standard.com/article/companies/bharat-biotech-ocugen-extend-agreement-to-market-covaxin-in-canada-121060301591_1.html I think authorization or approval is likely for the Novavax, Medicago and Ocugen vaccines in 2021. We could possibly even end up with 8 approved or authorized vaccines by the end of the year."], [29680, "2021-06-06T08:09:49Z", [0.0, 0.9, 0.09, 0.01, 0.0], ""], [101244, "2021-06-05T20:45:57Z", [0.0, 0.0, 0.0, 0.59, 0.41], "Hedging of bets due to the multitude of drug companies..."], [88452, "2021-06-05T04:46:03Z", [0.0, 0.0, 0.0, 0.86, 0.14], ""], [691, "2021-06-02T23:01:21Z", [0.0, 0.0, 0.6, 0.4, 0.0], ""], [14266, "2021-06-02T05:20:20Z", [0.0, 0.02, 0.47, 0.43, 0.08], ""], [100176, "2021-06-01T08:34:13Z", [0.05, 0.05, 0.1, 0.7, 0.1], ""], [86784, "2021-06-01T04:52:30Z", [0.0, 0.3, 0.35, 0.25, 0.1], "Currently approved:\n- Pfizer\n- Moderna\n- J&J I expect the FDA to drag their feet on approving most of the others. And within a few months, the incentive to jump through the hurdles of getting new vaccines approved in the US will disappear - almost everyone who wants one will already have one. So companies will decide to send their vaccines to other countries where most people are not yet vaccinated."], [59836, "2021-05-31T19:24:58Z", [0.0, 0.05, 0.1, 0.35, 0.5], "Had previously adjusted down due to concerns that Medicago's vaccine would be rejected by the FDA, going up again based on news that it won fast track designation from the FDA and is showing promising mid-stage trial results, with phase 3 trials having started in March (https://www.fiercepharma.com/manufacturing/medicago-s-plant-based-production-platform-bearing-fruit-gsk-partnered-covid-shot, https://www.fiercebiotech.com/biotech/medicago-gsk-post-positive-midphase-data-plant-derived-covid-19-vaccine)."], [98345, "2021-05-30T19:33:42Z", [0.0, 0.5, 0.4, 0.1, 0.0], ""], [48709, "2021-05-29T20:47:52Z", [0.0, 0.92, 0.08, 0.0, 0.0], "Three now are emergency approved "], [59836, "2021-05-29T15:51:34Z", [0.0, 0.05, 0.15, 0.5, 0.3], "Reducing for \"6 or more\" based on news that the FDA could decline new EUA requests (https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-may-not-review-new-covid-19-vaccine-eua-requests-during-pandemic-2021-05-25/)."], [88452, "2021-05-29T11:27:26Z", [0.0, 0.0, 0.0, 0.78, 0.22], "Convinced to raise \"6 or more\" by @belikewater . EDIT:\n\"While it is obvious that the EUA pathway is wide open for Covid-19 treatments, for vaccines the FDA has narrowed its guidance. On Tuesday it cautioned that for the remainder of the current pandemic it might decline to review and process further EUA requests, except those whose developers have 'already engaged with the agency'.\nThis exception would include Astrazeneca and Novavax\u2019s delayed candidates, which are subject to the Warp Speed programme. It would apparently not cover a third delayed project, Curevac\u2019s CVnCoV, which is to yield phase 2/3 data imminently; however, the point is moot, Curevac having deprioritised the US in favour of Europe.\"\nhttps://www.evaluate.com/vantage/articles/news/corporate-strategy/us-appetite-covid-19-treatments-remains-undiminished"], [99943, "2021-05-28T23:33:43Z", [0.0, 0.0, 0.1, 0.4, 0.5], "Current yes:\n* Pfizer\n* Moderna\n* J&J Maybe, in order of what I think is the likelihood of FDA authorization/approval happening in 2021:\n* Novavax (EUA application to be filed in 3rd quarter)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results)\n* Ocugen inactivated virus vaccine (\"The revised guidance was issued on the same day that Ocugen Inc (NASDAQ: OCGN) had submitted its master file to FDA in anticipation of requesting a EUA for the whole-virion inactivated COVID-19 vaccine Covaxin.\" https://finance.yahoo.com/news/fda-may-not-review-covid-162123410.html )\n* AZ (might apply for full approval directly; might not get approval by end of 2021)\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA authorization/approval will likely be sought.)\n* Sanofi mRNA\n* CureVac (will likely be approved in EU in 2021, but I don't see interest in applying for FDA approval; see, e.g., https://www.verywellhealth.com/curvac-covid-19-vaccine-5184398) Also note: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-may-not-review-new-covid-19-vaccine-eua-requests-during-pandemic-2021-05-25/\nFull approval could take some time. I'm sure it'll be expedited during the pandemic, but still, there are limits. We could possibly even end up with 8 approved or authorized vaccines by the end of the year. Update 6/6: Covaxin looks likely for 2021. \"Bharat Biotech and Ocugen expand their partnership to co-develop, supply and commercialise Covaxin, the Covid-19 vaccine from the Hyderabad-based vaccine maker, in Canada. Occugen already had the rights to commercialise Covaxin in the US. It will retain 45 per cent of the profits from sales of Covaxin in the US and Canada. Shankar Musunuri, chairman, chief executive and co-founder of Ocugen, said: \u201cAs we work towards the submission of the emergency use application in the US, we will simultaneously seek authorisation under interim order for emergency use in Canada.\u201d\"\nhttps://www.business-standard.com/article/companies/bharat-biotech-ocugen-extend-agreement-to-market-covaxin-in-canada-121060301591_1.html I think authorization or approval is likely for the Novavax, Medicago and Ocugen vaccines in 2021."], [55987, "2021-05-28T15:25:58Z", [0.0, 0.15, 0.61, 0.23, 0.01], "Adjusting to account for my apparent misreading of the question. "], [95503, "2021-05-27T12:07:28Z", [0.0, 0.07, 0.49, 0.37, 0.07], ""], [87342, "2021-05-27T07:07:07Z", [0.0, 0.02, 0.4, 0.53, 0.05], "I'm somewhat certain that AstraZeneca will be approved and potentially Novavax (or others).  https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html"], [48168, "2021-05-27T04:26:22Z", [0.0, 0.15, 0.3, 0.35, 0.2], ""], [48168, "2021-05-27T04:21:05Z", [0.8, 0.2, 0.0, 0.0, 0.0], ""], [34959, "2021-05-27T03:03:43Z", [0.0, 0.01, 0.53, 0.45, 0.01], ""], [83315, "2021-05-26T23:39:42Z", [0.0, 0.0, 0.1, 0.5, 0.4], "We already have 3-4"], [94872, "2021-05-26T17:38:52Z", [0.0, 0.12, 0.4, 0.36, 0.12], ""], [530, "2021-05-26T17:16:30Z", [0.0, 0.0, 0.5, 0.45, 0.05], ""], [46339, "2021-05-26T08:43:23Z", [0.0, 0.0, 0.5, 0.5, 0.0], ""], [72803, "2021-05-26T05:53:47Z", [0.0, 0.1, 0.3, 0.3, 0.3], ""], [52872, "2021-05-26T03:22:53Z", [0.0, 0.3, 0.4, 0.25, 0.05], ""], [24440, "2021-05-26T01:00:56Z", [0.0, 0.05, 0.25, 0.55, 0.15], ""], [101146, "2021-05-25T23:27:49Z", [0.0, 0.45, 0.43, 0.1, 0.02], "3 vaccines currently approved in USA.\nOxford-AstraZeneca is approved in EU, not yet approved in US, some controversy. I give 1 in 3 chance of approval. NovaVax has promising results, also some controversy. Another 1 in 3 chance. Unlikely that Gamaleya\u2019s Sputnik V receives Western approval, same for Chinese origin vaccines.\n"], [81555, "2021-05-25T22:45:32Z", [0.0, 0.07, 0.42, 0.45, 0.06], ""], [56744, "2021-05-25T22:39:11Z", [0.0, 0.53, 0.47, 0.0, 0.0], "I doubt any more will be approved, especially since it's politically vital for the democrats to end the pandemic and the FDA seems to be owned by pfizer "], [85522, "2021-05-25T21:46:49Z", [0.0, 0.0, 0.08, 0.26, 0.66], ""], [78366, "2021-05-25T21:45:32Z", [0.0, 0.0, 0.0, 1.0, 0.0], ""], [37871, "2021-05-25T20:34:56Z", [0.02, 0.4, 0.4, 0.1, 0.08], "I think there is a good chance the Astrazenica vaccine will be approved,but not certain.  Others beign approved (like those from Russian and China) seem like long shots, as does the approval by the end of the year of any new vaccine."], [422, "2021-05-25T16:16:47Z", [0.0, 0.0, 0.64, 0.36, 0.0], ""], [55987, "2021-05-25T15:36:31Z", [0.06, 0.82, 0.1, 0.02, 0.0], "The more I look at this, the more convinced I become that the timeline is going to get in the way. The full FDA approval process takes 6-10 months, meaning that the current applications won't be approved before December. There is still a chance of Pfizer or Moderna getting full approval and falling off the EUA list, but the odds are getting slim. I hesitate on the list getting longer mostly because the public health emergency is winding down, removing the need for EUA application approval. My assumption here is that the FDA will force other vaccines to go to full approval application. "], [100596, "2021-05-25T15:30:23Z", [0.0, 0.0, 0.3, 0.6, 0.1], ""], [59836, "2021-05-24T15:18:32Z", [0.0, 0.05, 0.15, 0.35, 0.45], "Revising based on comments (@SE_Meyer @belikewater)"], [59836, "2021-05-23T15:18:04Z", [0.0, 0.1, 0.25, 0.65, 0.0], "Cautiously optimistic given the long timeline and some promising news from ASTRAZENECA (although results not final yet):  https://www.reuters.com/business/healthcare-pharmaceuticals/uk-analysis-finds-two-doses-astrazeneca-covid-19-vaccine-85-90-effective-2021-05-20/. There is still the issue of blood clots, which could be a barrier to approval, but European scientists say it's still worth the risks (https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots). Novavax originally planned to submit in April, but now say they won't file until at least July because of manufacturing issues (https://www.nytimes.com/2021/05/11/health/covid-vaccine-novavax-delays.html). However, that still gives 5 months for error, and Novavax has been in the works for a while."], [96828, "2021-05-23T11:21:45Z", [0.0, 0.21, 0.43, 0.29, 0.07], "If 4 is more likely, than so is the tendency for 5 to be greater than 3. Therefore I shifted percentage points from 3 bin to 5 bin and some to the 6 bin to widen the net for a possible but unlikely approval spree. I understand the justification for 3 remaining the status quo because America doesn't need them as much anymore, but it is quite possible that officials want to push closer to herd immunity and give the widely acceptable and considered options a shot, pun unintended. However, what the crowd is essentially saying as of late, is a 94% chance it's either 4 or 5. I think that should be more like 80%, with the 6 bin more likely. Therefore, a plausible revised forecast is 7, 47, 33, 13 (lowest bin to highest bin). For now, I'll stay at my current forecast to reflect my uncertainty about whether the CDC or FDA wants more vaccines and give more weight to the fact that months have passed since the J&J one, with less need to have more - and therefore a 6 bin with <10%."], [96828, "2021-05-23T11:14:34Z", [0.0, 0.22, 0.44, 0.3, 0.04], ""], [96828, "2021-05-23T11:13:19Z", [0.0, 0.3, 0.44, 0.22, 0.04], "With the downfall trend in vaccination rates, there may be some kind of campaign, intentional or not, to provide at least one more option for America but it has been a while so the slowness in approval and the decreased urgency for it in terms of COVID rates and vaccine availability makes me doubt the 6 or more bin."], [25755, "2021-05-22T15:45:24Z", [0.0, 0.01, 0.37, 0.56, 0.06], ""], [14266, "2021-05-22T07:14:39Z", [0.0, 0.0, 0.58, 0.37, 0.05], ""], [29680, "2021-05-21T09:24:31Z", [0.0, 0.8, 0.19, 0.01, 0.0], "Expecting the Novavax vaccine to complete trials in June or later according to the WP [https://www.washingtonpost.com/health/2021/05/10/novavax-coronavirus-vaccine/]. If Pfizer and Moderna are appropriate indicators, the Novavax vaccine could be approved within a month of submission, but it's likely that Pfizer and Moderna (and us) were lucky to see miraculous results just weeks before the winter season when cases were expected to overwhelm hospitals further. New daily cases were eight times higher than they are now, and the rate of daily first dose vaccinations is dropping pretty fast. As others mentioned, it seems it would be more difficult for the FDA to justify further vaccine EUAs. More plausible would be if Novavax was fast-tracked and then approved in December 2021. 150 days is the shortest time frame I found for non-EUA FDA approvals. If Novavax can't complete Phase III trials by early July 2021, and it's not emergency-use-authorized, it seems it wouldn't be approved by the FDA until early 2022. Have not read up on the other vaccines, but any vaccines that don't release Phase III results before early July will likely need EUA to be approved before 2022."], [99943, "2021-05-20T13:30:11Z", [0.0, 0.0, 0.1, 0.45, 0.45], "Positive results for Medicago. (Hi @SE_Meyer.)\nhttps://www.precisionvaccinations.com/2021/05/18/plant-derived-covid-19-vaccine-candidate-found-effective\nAlso, the Novavax timeline has been pushed back to filing for EUA in the 3rd quarter.\nhttps://thehill.com/policy/healthcare/552740-novavax-to-apply-for-fdas-emergency-authorization-in-2021s-third-quarter Here are my lists now:\nYes:\n* Pfizer\n* Moderna\n* J&J\n* Novavax (EUA application to be filed in 3rd quarter) Maybe, in order of what I think is the likelihood of authorization/approval happening:\n* Sanofi GSK protein (\"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Trials funded by BARDA/DoD, so FDA approval will likely be sought.)\n* AZ (might apply for full approval directly; might not get approval by end of 2021)\n* Medicago (got FDA Fast Track designation in Feb; positive Phase 2 results)\n* Sanofi mRNA\n* CureVac (don't see interest in applying for FDA approval, though)"], [530, "2021-05-19T15:18:58Z", [0.0, 0.0, 0.5, 0.45, 0.05], ""], [22689, "2021-05-18T15:19:29Z", [0.0, 0.2, 0.8, 0.0, 0.0], ""], [99943, "2021-05-17T21:53:12Z", [0.0, 0.0, 0.1, 0.5, 0.4], "Thanks to @SE_Meyer for the news that the Sanofi/GSK protein vaccine is back. \"The companies are projecting a possible regulatory approval in the fourth quarter of 2021.\" Which country/countries? I've seen similar statements in a couple articles but no further clarity. The vaccine was produced in part under an arrangement with the US gov't, and some trials will be conducted in the US, so it would seem likely that they'd seek FDA approval.\nhttps://www.statnews.com/2021/05/17/sanofi-gsk-results-covid-19-vaccine/ Here are my lists now:\nYes:\n* Pfizer\n* Moderna\n* J&J\n* Novavax (authorization likely imminent) Maybe:\n* AZ\n* Medicago (apparently got FDA Fast Track designation in Feb)\n* Sanofi mRNA\n* Sanofi GSK protein\n* CureVac"], [88452, "2021-05-17T18:11:03Z", [0.0, 0.0, 0.0, 0.88, 0.12], "So there was promising data from the Sanofi GSK development, which will enter clinical trial phase 3 soon.\nWhat would be #6? @belikewater "], [95503, "2021-05-17T18:07:55Z", [0.0, 0.07, 0.49, 0.37, 0.07], ""], [34959, "2021-05-17T13:20:48Z", [0.0, 0.01, 0.58, 0.4, 0.01], ""], [29680, "2021-05-17T04:51:28Z", [0.0, 0.8, 0.2, 0.0, 0.0], ""], [100742, "2021-05-17T02:24:14Z", [0.05, 0.6, 0.2, 0.1, 0.05], "It is not obvious that the problem (as of today) is the quality of the approved vaccines or their availability. As such I don\u2019t see why the authorities will be focussing on further approvals. Plus there is the \u201cbuy American\u201d angle. "], [87155, "2021-05-16T17:11:19Z", [0.0, 0.2, 0.55, 0.25, 0.0], ""], [98345, "2021-05-16T17:05:14Z", [0.0, 0.7, 0.2, 0.1, 0.0], "April 9:\nhttps://www.ctvnews.ca/health/coronavirus/government-vaccine-advisers-say-they-don-t-foresee-astrazeneca-vaccine-being-used-in-the-u-s-1.5381038\n'\"We already have contracted for enough vaccines, from Moderna and from Pfizer and from [Johnson &Johnson],\" he said. \"There is no plan to immediately start utilizing the AstraZeneca [vaccine] even if it gets approved through the EUA, which it very well might.\"\nFauci said it wasn't because of the AstraZeneca vaccine itself, but rather that it's not necessary in the US right now.\n\"It's not any indictment against the product. We just have a lot of vaccines,\" he said.' Given the lack of need, even if there is good evidence for the safety and efficacy of AZ, Novavax, and potentially others, there's just not a lot of pressure to rapidly approve additional vaccines. I think there would need to be some compelling reason, e.g. more effective against rising variants, etc. Pfizer, Moderna, and J&J are already approved, so that's 3. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html"], [94872, "2021-05-16T07:34:20Z", [0.0, 0.12, 0.4, 0.36, 0.12], ""], [45594, "2021-05-16T06:54:15Z", [0.0, 0.0, 0.6, 0.3, 0.1], ""], [34815, "2021-05-16T04:38:48Z", [0.0, 0.0, 1.0, 0.0, 0.0], ""], [100273, "2021-05-16T02:37:53Z", [0.0, 0.0, 0.2, 0.7, 0.1], "The unknowns are many, but the rewards are huge. "], [95503, "2021-05-15T12:55:50Z", [0.0, 0.07, 0.46, 0.4, 0.07], ""], [41352, "2021-05-14T17:29:19Z", [0.05, 0.35, 0.55, 0.05, 0.0], ""], [530, "2021-05-14T15:51:35Z", [0.0, 0.0, 0.6, 0.35, 0.05], ""], [20156, "2021-05-14T08:35:43Z", [0.0, 0.0, 0.62, 0.31, 0.07], ""], [14826, "2021-05-13T16:11:01Z", [0.0, 0.15, 0.33, 0.4, 0.12], ""], [81187, "2021-05-13T15:57:58Z", [0.0, 0.0, 1.0, 0.0, 0.0], ""], [55987, "2021-05-13T15:24:16Z", [0.22, 0.48, 0.26, 0.04, 0.0], "Revising conditional probabilities to better account for timing constraints. "], [99706, "2021-05-13T15:20:07Z", [0.0, 0.0, 0.5, 0.45, 0.05], ""], [95503, "2021-05-13T14:43:13Z", [0.0, 0.07, 0.4, 0.4, 0.13], ""], [691, "2021-05-12T17:10:12Z", [0.0, 0.0, 0.62, 0.38, 0.0], ""], [98850, "2021-05-12T15:57:02Z", [0.0, 0.02, 0.67, 0.3, 0.01], "This is a tricky one. We're having to weigh the likelihood that the current vaccines stay under the EUA in some form as well as determine whether other vaccines, and which vaccines, might meet the criteria for EUA inclusion. Based on my understanding of full FDA approval from this article - https://www.wkyc.com/article/news/health/coronavirus/vaccine/difference-between-emergency-use-authorization-and-full-fda-approval-coronavirus-vaccines/95-f2a7a6ba-eeee-4352-b3c7-8dce70cfba67 - it seems like the Pfizer vaccine has a chance at being fully approved, but only for people over 16. This would keep it on the list of EUA vaccines for 12-15 year olds and I don't see that changing. I'm using a list from @Emking with my own percentages. I don't foresee any revocations of the approved 3 during the course of this year, but cannot assume 100% that they'll be around because that's just poor forecasting. \nModerna 95%\nPfizer 95%\nJ&J 95%\nAstraZeneca 80%\nNovavax 45%\nSome other 5% So with all of this said, I'm throwing out 2 or fewer because no way that happens. I'm also thinking the percentage chance it winds up at 3 on Dec 31, 2021 is incredibly low to where I am giving it a minimal chance. Probability of 4 is likely since AZ has been deployed across much of the world and they have filed paperwork. So I'm mostly wondering if Novavax comes through with their expected July filing and will be keeping an eye on that. As of right now, I'm more skeptical than not on this. https://www.pharmacytimes.com/view/how-the-fda-s-expedited-eua-process-works"], [100184, "2021-05-12T11:29:29Z", [0.0, 0.0, 0.56, 0.42, 0.02], ""], [88452, "2021-05-12T08:09:04Z", [0.0, 0.0, 0.0, 0.88, 0.12], ""], [95503, "2021-05-12T07:54:32Z", [0.0, 0.1, 0.54, 0.32, 0.04], ""], [97375, "2021-05-12T07:24:48Z", [0.0, 0.0, 0.59, 0.41, 0.0], ""], [84880, "2021-05-12T01:57:53Z", [0.0, 0.06, 0.6, 0.33, 0.01], ""], [34959, "2021-05-12T01:47:16Z", [0.0, 0.02, 0.51, 0.46, 0.01], ""], [99467, "2021-05-11T20:59:40Z", [0.0, 0.0, 0.18, 0.24, 0.58], ""], [95503, "2021-05-11T20:44:11Z", [0.0, 0.14, 0.53, 0.3, 0.03], ""], [95503, "2021-05-11T17:56:28Z", [0.0, 0.2, 0.49, 0.28, 0.03], ""], [54186, "2021-05-11T17:18:06Z", [0.0, 0.0, 0.0, 0.0, 1.0], ""], [95503, "2021-05-11T13:18:23Z", [0.0, 0.2, 0.49, 0.27, 0.04], ""], [95503, "2021-05-11T11:08:03Z", [0.0, 0.22, 0.48, 0.27, 0.03], ""], [14266, "2021-05-11T03:22:06Z", [0.0, 0.0, 0.6, 0.4, 0.0], ""], [100971, "2021-05-11T01:28:06Z", [0.0, 0.0, 0.75, 0.25, 0.0], ""], [88452, "2021-05-10T23:11:22Z", [0.0, 0.0, 0.12, 0.88, 0.0], "https://thehill.com/policy/healthcare/552740-novavax-to-apply-for-fdas-emergency-authorization-in-2021s-third-quarter \"In its first quarter report, Novavax also released that an early study in animals of a combination vaccine for COVID-19 and the flu led to a positive immune antibody response.\" @belikewater If this combination vaccine is ready in time, it would lead to a second  separate EUA, wouldn't it? (they likely won't have all the data from studies in 2021, imho...)"], [92593, "2021-05-10T20:21:57Z", [0.0, 0.0, 0.3, 0.4, 0.3], "There's a good chance that the variants will throw up a need for new vaccines and that creates the possibility for emergency approval for new vaccines. "], [422, "2021-05-10T17:36:57Z", [0.0, 0.0, 0.44, 0.56, 0.0], ""], [84880, "2021-05-10T16:10:44Z", [0.0, 0.33, 0.47, 0.19, 0.01], "With demand dropping, can the FDA justify another EUA? Only one additional jab sounds plausible, and that is in terms of going down the normal route.\nhttps://en.wikipedia.org/wiki/List_of_COVID-19_vaccine_authorizations\nhttps://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html"], [93409, "2021-05-10T15:14:41Z", [0.0, 1.0, 0.0, 0.0, 0.0], ""], [55987, "2021-05-10T14:59:51Z", [0.57, 0.31, 0.1, 0.01, 0.01], "Baseline assumption is that there is not time for another new vaccine to get approval in this window, other than AstraZeneca and Novavax. This leaves the highest reasonable outcome at five (including the three already approved). The question then turns to whether the new two get authorization and if the existing three remain under an EUA. On that front, Pfizer is already pursuing full FDA approval and the J&J pause highlights the risk of revocation. AstraZeneca is contemplating skipping EUA. Here are the initial probabilities I've applied of each vaccine being under an EUA on Dec. 31:  Moderna 90%\nPfizer 40%\nJ&J 60%\nAstraZeneca 25%\nNovavax 15%\nSome other 5% The joint probabilities of these discrete estimates are my forecast. "], [95503, "2021-05-10T14:31:00Z", [0.0, 0.22, 0.47, 0.25, 0.06], ""], [87827, "2021-05-10T14:27:18Z", [0.01, 0.03, 0.21, 0.4, 0.35], "Here's what I'm estimating for the probability of approval of each vaccine by end of year: Astrazeneca: 55%\nNovavax: 80%\nSanofi/GlaxoSmithKline: 55%\nOther (Combined probability of Curevac, a Chinese vaccine, or others I may not be considering): 25% Assuming I did the math right in combining the possible scenarios I come up with the above probabilities. Spreadsheet with the math (feel free to copy and change with your own probabilities or for other uses): https://docs.google.com/spreadsheets/d/1BEukXZ_IOMEESxaMPD216qugBo7kppVRbXuqp-pPmNg/edit?usp=sharing"], [29054, "2021-05-10T13:55:42Z", [0.0, 0.0, 0.57, 0.43, 0.0], ""], [95503, "2021-05-10T13:35:05Z", [0.0, 0.25, 0.52, 0.2, 0.03], ""], [87889, "2021-05-10T11:02:47Z", [0.0, 0.45, 0.32, 0.22, 0.01], ""], [77411, "2021-05-10T10:11:43Z", [0.0, 0.2, 0.5, 0.3, 0.0], ""], [100664, "2021-05-10T08:33:10Z", [0.0, 0.01, 0.2, 0.55, 0.24], ""], [100742, "2021-05-10T02:52:14Z", [0.05, 0.4, 0.25, 0.25, 0.05], ""], [100273, "2021-05-10T02:11:09Z", [0.0, 0.0, 0.5, 0.5, 0.0], "Plus 1"], [99070, "2021-05-10T00:40:35Z", [0.0, 0.46, 0.46, 0.08, 0.0], ""], [95503, "2021-05-09T18:18:56Z", [0.0, 0.3, 0.46, 0.2, 0.04], ""], [691, "2021-05-09T17:26:53Z", [0.0, 0.25, 0.53, 0.22, 0.0], ""], [88452, "2021-05-09T11:05:03Z", [0.0, 0.0, 0.12, 0.88, 0.0], ""], [92079, "2021-05-09T01:40:40Z", [0.0, 0.0, 1.0, 0.0, 0.0], ""], [22689, "2021-05-09T01:37:02Z", [0.0, 0.4, 0.6, 0.0, 0.0], ""], [22689, "2021-05-09T01:35:53Z", [0.0, 0.0, 0.8, 0.2, 0.0], ""], [98210, "2021-05-08T19:52:43Z", [0.0, 0.61, 0.39, 0.0, 0.0], ""], [691, "2021-05-08T18:06:27Z", [0.0, 0.24, 0.43, 0.33, 0.0], ""], [99993, "2021-05-08T17:40:59Z", [0.0, 0.75, 0.25, 0.0, 0.0], ""], [100940, "2021-05-08T15:42:41Z", [0.01, 0.25, 0.6, 0.13, 0.01], "There are currently 3, and looking at the pipeline of others, where they are from, it's very possible that it stays at that number, but I think it more likely than not that one more will be approved. Given what we see of politics I think it's increasingly unlikely that many of the others that could be approved will be."], [100941, "2021-05-08T15:37:39Z", [0.0, 0.0, 0.4, 0.45, 0.15], ""], [95503, "2021-05-08T11:58:35Z", [0.0, 0.34, 0.35, 0.25, 0.06], ""], [53391, "2021-05-08T11:55:26Z", [0.0, 0.8, 0.2, 0.0, 0.0], "3 currently with EUA Pfizer,moderna, and J&J.  The FDA will NOT issue another EUA for any other vaccine unless it shows a subtantial benefit over the current 3. None of the other vaccine in development offer any greater benefit than the existing 3 for the current variants of concern. Possibly some variant will rise up in October and one of the other vaccines will be superior at providing protection. Full approval requires 6 to 10 months and 6 months is fast.  The FDA will focus BLA activity on the current three. I say this because once a BLA is approved then the vaccine can be mandated for use by public institutions.  There is barely time to get pfizer approved by year end."], [95503, "2021-05-08T11:42:50Z", [0.0, 0.27, 0.35, 0.23, 0.15], ""], [99780, "2021-05-08T11:22:22Z", [0.0, 0.56, 0.41, 0.02, 0.01], "Baseline is the three already approved and highly highly unlikely to be removed from circulation. Given an abundance of vaccines in the US already, I predict that EUA will not be issued for any additional vaccines, so the longer-timeline for full approval will have to apply to AZ, Sanofi, or anything else currently in the pipeline. (Just yesterday, Pfizer applied for full approval.) From a public health policy standpoint I expect emphasis to be placed on reducing hesitancy domestically and (belatedly) ramping up production of existing vaccines globally. I think less pressure will be placed on expediting approval of vaccines in the US; they already have enough. I will revise my estimates if I see any news about a vaccine maker seeking EUA or full approval from the FDA, or news indicating (1) a manufacturer is expected to do so, or (2) the FDA intends to maintain an aggressive posture toward approving vaccines, and not revert back to its historical torpor."], [99943, "2021-05-08T03:41:30Z", [0.0, 0.0, 0.1, 0.68, 0.22], "Just saw that AZ may go straight to full approval and skip EUA. That would require US Govt approval because of AZ's contract with the gov't. It seems that would add a few more months to the entire process, but it sounds like it would still likely go through by the end of the year, although that would need to be watched.\nhttps://www.wsj.com/articles/astrazeneca-weighs-seeking-full-u-s-approval-for-covid-shot-skipping-emergency-use-application-11620423584 https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html\nSanofi's protein-based vaccine didn't do so well, but they've reformulated it with the goal of eliciting stronger immune responses in older people. But they don't think that will be available in 2021. But their mRNA vaccine trials are still going on; they anticipate having Phase 1/2 trial results available in the third quarter. So it's not clear to me whether they'd have enough data to get EUA by the end of the year. Probably not. They could also not go for EUA but rather straight to full approval, I don't know. So here are the possibilities I'm thinking of:\nYes:\n* Pfizer\n* Moderna\n* J&J\n* Novavax (authorization likely imminent) Maybe:\n* AZ\n* Medicago (apparently got FDA Fast Track designation in Feb)\n* Sanofi mRNA\n* CureVac Of the maybes, I'd think the AZ and Medicago would have the strongest chances. To me, the only question about AZ is time. If they go for full approval, I don't think it's a complete given that it will happen in 2021. I think Sanofi probably won't have enough time. I haven't seen that CureVac is interested in getting FDA EUA, but they're far enough along that they could. But I think it's likely that at least one of the \"maybes\" gets approved or authorized in 2021. Need to watch this over time."], [87889, "2021-05-07T22:41:24Z", [0.0, 0.22, 0.39, 0.38, 0.01], ""], [99943, "2021-05-07T21:52:03Z", [0.0, 0.0, 0.0, 0.8, 0.2], ""], [99943, "2021-05-07T21:48:03Z", [0.0, 0.0, 0.0, 0.9, 0.1], "3 authorized to date. AZ and Novavax probably within the next month or 2. The only real question is the Sanofi mRNA vaccine. And CureVac, but I don't think they'll get approval/authorization before the end of the year.\nhttps://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html"], [95503, "2021-05-07T20:29:32Z", [0.0, 0.2, 0.35, 0.2, 0.25], ""], [85522, "2021-05-07T20:21:43Z", [0.0, 0.0, 0.01, 0.18, 0.81], "There are three currently approved or authorised for emergency use in the USA: Pfizer, Moderna and Johnson & Johnson.  AstraZeneca is not currently authorised but is seeking authorisation or approval. There are four more in phase 3 which may be proven to be effective this year: Novavax (US)\nCureVac (Germany)\nMedicago (Canadian)\nValneva (France/UK) Novavax is already in production and CureVac says it is likely to be approved by the EMA during the summer, so I think it's very likely that both will also be approved or authorised by the FDA. I don't believe that any of the Chinese or Russian vaccines will be authorised or approved but I should probably check to see if they're trying. It's possible that the FDA might de-authorise AZ or J&J, so I'll allow a slight possibility that both will, but I think it's thoroughly unlikely that both will be de-authorised and no other vaccines are cleared for use."], [88452, "2021-05-07T17:38:53Z", [0.0, 0.0, 0.0, 1.0, 0.0], ""], [95503, "2021-05-07T17:24:43Z", [0.0, 0.25, 0.47, 0.23, 0.05], ""]], "open_date": "2021-05-07T17:00:18Z", "close_date": "2022-01-01T08:01:18Z"}